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ABAD: Aβ-binding alcohol dehydrogenase 
AD: Alzheimer disease  
ADDLs: Aβ-derived diffusible ligands  
Aβ: Amyloid beta 
AP: Autophagosome 
APP: Amyloid beta (A4) precursor protein  
ATG: autophagy related proteins  
ATP: Adenosine triphosphate 
AVs: Autophagic vacuoles  
CCCP: Carbonyl cyanide m-chlorophenylhydrazone  
CMA: Chaperone-mediated autophagy 
COX4: Complex IV  
DLP1: Dynamin-like protein 1 
DMEM: Dulbecco´s modified Eagle´s medium  
DAPI: 4',6-Diamidino-2-Phenylindole, Dihydrochloride  
EB: Embryoid body 
ER: Endoplasmic reticulum 
FAD: Familial Alzheimer disease 
FBS: Fetal Bovine Serum 
FL: Full-length 
GAPDH: Glyceraldehyde-3-phosphate dehydrogenase  
GTP: Guanosine triphosphate 
IMM: Inner mitochondrial membrane 
iNs: Induced neurons 
iPSC: induced pluripotent stem cell  
IP3R: Inositol triphosphate receptor 
KLF4: Kruppel-like factor 4 
KO: Knock-out 
LAMP1: Lysosomal-associated membrane protein 1  
MAM: Mitochondria-associated ER membranes 
MAP1LC3/LC3: Microtubule-associated protein 1 light chain 3  
MAPT/Tau: Microtubule-associated protein tau 
Mfn: Mitofusin 
MPP: Mitochondrial processing protease 
mtDNA: mitochondrial DNA 
NBR1: Neighbor of BRCA1 gene 1 protein 
NDP52: Nuclear dot protein 52 kDa 
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NTF: Neurofibrillary tangles 
OCT4: Octamer-binding transcription factor 4 
OMM: Outer mitochondrial membrane 
OPA1: Optic atrophy 1 
PHF: Paired helical filaments 
PSEN: Presenilin  
PARK2: Parkin RBR E3 ubiquitin protein ligase  
PARL: Presenilin-associated rhomboid-like 
PINK1: PTEN-induced putative kinase 1  
ROS: Reactive oxygen species  
SCaMC-1: Short calcium-binding mitochondrial carrier 1  
SAD: Sporadic Alzheimer disease 
SOX2: Sex determining Region Y-box 2 
SQSTM1: Sequestosome 1 
TOMM20: Translocase of outer mitochondrial membrane 20 homolog  
VDAC1: Voltage-dependent anion channel 1 
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Alzheimer disease (AD) is a neurodegenerative disorder characterized by the accumulation 
of Aβ peptide and hyperphosphorylated Tau protein. Mitochondrial dysfunction and oxidative 
damage have been previously reported not only in the vulnerable regions of affected brain but also in 
peripheral cells in the disease. Autophagy has been demonstrated to play a fundamental role in AD 
related proteinopathy. Moreover, anomalies at different levels of autophagy pathway have been 
described suggesting that autophagy failure might be considered an early event of the disease. 
Therefore, the aim of this work was the study of autophagy pathway besides mitochondrial recycling 
process in human cellular models of both familial and sporadic types of AD.  
The overexpression of APP in human fibroblasts demonstrated an activation of autophagy 
flux due to an enhanced degradation phase correlating with higher lysosomal activity. Increased 
mitochondrial content revealed a defect in mitophagy due to defective labeling of damaged 
mitochondria by PARK2. The addition of Tau to APP overexpression model aggravated the mitophagy 
dysfunction leading to unachievable recovery of mitochondrial membrane potential after an insult 
that resulted in the further accumulation of dysfunctional mitochondria labeled by PINK1.  
The study of fibroblasts derived from familial AD patients associated to presenilin mutation 
revealed a deregulation of autophagy degradation phase correlating with lysosome acidification 
deficiency leading to accumulation of autophagic vesicles. This resulted in a mitochondrial recycling 
failure that caused the accumulation of mitochondria and PARK2. Worsened mitophagy dysfunction 
was observed in neurons derived from induced pluripotent stem cells harboring the same presenilin 
mutation triggering increased accumulation of mitochondria, PARK2 and PINK1. 
Fibroblasts derived from sporadic AD patients demonstrated compromised mitochondrial 
dynamics and function as well as deficient autophagy induction and lysosomal anomalies resulting in 
the accumulation of oxidized and ubiquitinated proteins. Mitophagy impairment has been proven in 
these cells due to diminished PARK2 recruitment that caused the accumulation of depolarized 
mitochondria and PINK1. Patients’ hippocampal samples at early stages of the disease exhibited 
similar mitophagy alterations showing abnormally increased mitochondrial content together with 
accumulation of PINK1. 
Overexpression of PARK2 in sporadic AD fibroblasts diminished ubiquitinated proteins 
accumulation, improved its targeting to mitochondria and potentiated autophagic vesicle synthesis 
allowing the reversion of mitophagy failure. This suggests that autophagy enhancement is a powerful 
therapeutic strategy. 
Our findings indicate that, although there are differences in the deregulation pattern of the 
mitochondrial recycling process in sporadic and familial AD models, both converge in the same 
mitophagy failure that causes the accumulation of dysfunctional mitochondria. 
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La enfermedad de Alzheimer (EA) es un trastorno neurodegenerativo caracterizado por la 
acumulación del péptido Aβ y la proteína Tau hiperfosforilada. Se ha demostrado un fallo en la 
función mitocondrial así como un daño oxidativo no solo en las regiones afectadas en el cerebro si no 
en células periféricas en la enfermedad. Se han descrito anomalías en las diferentes etapas de la 
autofagia sugiriendo que la insuficiencia autofágica podría ser considerada un evento temprano de la 
patología. Teniendo en cuenta estos antecedentes, el objetivo de este trabajo fue el estudio del 
proceso de autofagia así como el mecanismo de reciclaje mitocondrial en modelos celulares humanos 
tanto de la forma familiar como esporádica de la EA.  
La sobreexpresión de APP en fibroblastos humanos demostró una activación de la fase 
degradativa de la autofagia en correlación con una mayor actividad lisosomal. El incremento del 
contenido mitocondrial reveló un defecto en mitofagia debido a un incorrecto marcaje de 
mitocondrias dañadas por PARK2. La adición de Tau al modelo de sobreexpresión de APP agravó la 
disfunción en mitofagia que se reflejó en la falta de recuperación del potencial de membrana, lo que 
provocó una mayor acumulación de mitocondrias no funcionales marcadas con PINK1.  
El estudio de fibroblastos de pacientes de EA familiar asociados a una mutación en 
presenilina mostró una desregulación de la fase degradativa de la autofagia en correlación con una 
incorrecta acidificación de los lisosomas, lo que resultó en la acumulación de vesículas autofágicas. 
Esto provocó un fallo en el reciclaje mitocondrial que causó la acumulación de mitocondrias y 
PARK2. Las neuronas derivadas de células madre pluripotentes inducidas (iPSC) con la misma 
mutación en presenilina presentaron un empeoramiento del proceso de mitofagia que conllevó a un 
aumento de la acumulación mitocondrial, PARK2 y PINK1.  
Los fibroblastos derivados de pacientes de EA esporádica manifestaron una dinámica y 
función mitocondrial menoscabada, así como una inducción de autofagia deficiente unida a 
anomalías lisosomales, dando como resultado la acumulación de proteínas oxidadas y ubiquitinadas. 
En estas células se demostró un deterioro en mitofagia debido a un menor reclutamiento de PARK2 
que causó la acumulación de mitocondrias despolarizadas y PINK1. Muestras de hipocampo de 
pacientes en etapas tempranas de la enfermedad presentaron alteraciones similares en mitofagia con 
acumulación anormal de mitocondrias y PINK1.  
La sobreexpresión de PARK2 en fibroblastos de EA esporádica generó una disminución de los 
niveles de proteínas ubiquitinadas, mejoró su reclutamiento a la mitocondria, además de potenciar la 
síntesis de vesículas autofágicas permitiendo la reversión del defecto en mitofagia. Esto sugiere que 
la mejora del proceso de autofagia es una poderosa estrategia terapéutica.  
Nuestros resultados indican que, aunque existen diferencias en el patrón de desregulación 
del proceso de reciclaje mitocondrial en los modelos esporádicos y familiares de la EA, ambos 
convergen en el mismo fallo en mitofagia que causa la acumulación de mitocondrias no funcionales. 
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1. Alzheimer Disease 
Alzheimer disease (AD) is a progressive and fatal neurodegenerative disorder and the 
leading cause of dementia accounting for 50–70% of cases. Due to the fact that the primary risk 
factor for AD is old age, the prevalence of the disease is increasing dramatically with progressive 
ageing of population in developed countries. The World Alzheimer Report revealed that over 46 
million people worldwide live with dementia in 2015 and this number will almost double every 20 
years.  
AD was first described by Alois Alzheimer in 1907 (Alzheimer et al, 1995), and it is 
manifested by cognitive and memory deterioration, progressive impairment of activities of daily 
living, as well as a variety of neuropsychiatric symptoms and behavioral disturbances (Cummings, 
2004).  
AD is classified in two different types: familial Alzheimer disease (FAD) and sporadic 
Alzheimer disease (SAD). FAD is early-onset AD (<65 years) and genetically heterogeneous with 
autosomal dominant inheritance (Tanzi et al, 1996). Only less than 5% of AD cases can be related to 
mutations in Amyloid beta (Aβ) precursor protein (APP) located in chromosome 21, Presenilin 1 
(PSEN1) in chromosome 14 and Presenilin 2 (PSEN2) in chromosome 1 (Rademakers et al, 2003). 
SAD or late-onset AD (>65 years) which accounts for more than 95% of cases, is a multifactorial 
disease where several genes are implicated in increasing the risk as well as environmental 
factors. Undoubtedly, the main risk factor is aging since the incidence of AD increases exponentially 
from 65 years (Jicha et al, 1999; Kawas & Corrada, 2006; Kukull et al, 2002). Moreover, it has been 
described different types of lifestyle risk factors such as smoking, hypertension, obesity, 
atherosclerosis, hypercholesterolemia, previous brain injury or diabetes mellitus type II (Carlsson, 
2010; de Toledo Ferraz Alves et al, 2010; Fotuhi et al, 2009; Schmidt et al, 2001). On the other hand, 
the polymorphic apolipoprotein E (apoE) gene confers susceptibility to develop the disease. The 
apoE4 allele is the largest known genetic risk factor for late-onset SAD in a variety of ethnic groups in 
contrast to apoE2 and apoE3 alleles (Coon et al, 2007; Corder et al, 1993; Raber et al, 2004; 
Strittmatter et al, 1993).  
The confirmed diagnosis of AD requires the presence of two major neuropathological lesions: 
accumulation of extracellular amyloid beta (Aβ) senile plaques and intracellular microtubule-
associated protein Tau (MAPT/Tau) neurofibrillary tangles. These structures are normally visible at 
the patient autopsy although increasing efforts has been made to develop techniques that allow their 
identification in vivo (Fodero-Tavoletti et al, 2011; Klunk et al, 2004). However, it is widely accepted 
that Alzheimer is a silent neurodegeneration where neuronal damage occurs before the diagnosis, 
and plaques, tangles and cellular degeneration appear previous to the onset of disease symptoms.  
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1.1 APP & amyloid plaques 
Amyloid precursor protein (APP) is an integral membrane protein expressed in various 
organs and tissues which belongs to a larger evolutionarily conserved APP superfamily found in 
diverse organisms from nematode to mammals. Although still not fully understood, the role of APP in 
normal functioning of the brain and other organs had been intensively studied. The protein sequence 
analysis of the APP superfamily members strongly suggests that the normal function of APP relates to 
cell–cell interaction and cell–substrate adhesion (Coulson et al, 2000; Soba et al, 2005). Moreover, it 
has been implicated as a regulator of synapse formation (Priller et al, 2006), neural plasticity (Turner 
et al, 2003), iron export (Duce et al, 2010) and hormonal regulation (Gallego et al, 2010; Porayette et 
al, 2009). However, there are some data suggesting that membrane localization and processing of 
APP in neurons differ from those in peripheral cells (e.g. lymphoid cells, hepatocytes or kidney) 
which suggests that functioning of this transmembrane holoprotein and production of Aβ in the brain 
is a critical determinant of its receptor-transducer properties unique to this organ (Jung et al, 1996). 
The Aβ senile plaques are extracellular deposits mainly composed by Aβ peptide crucially 
involved in Alzheimer disease but also shown in brains of advance age (Dickson et al, 1992; Morris et 
al, 1996; Wolf et al, 1999), without evidence of a cognitive deficit associated with their presence 
(Aizenstein et al, 2008; Katzman et al, 1988; Rowe et al, 2007). The peptides result from 
the sequential proteolytic cleavage of APP (Masters et al, 1985), which is proteolyzed by α-, β- y γ-
secretase to yield Aβ. The sequential cleavage of α- and γ-secretase generates a small non-
amyloidogenic peptide of 3 kDa, (Haass et al, 1993; Haass et al, 1992). Consecutive cleavages of β- 
and γ-secretase generates a peptide of 40 or 42 amino acids (Aβ40 or Aβ42), which is released into 
the extracellular space (Selkoe, 2001). Aβ42 is more hydrophobic than Aβ40, and tends to aggregate 
and fold in β-sheet structure, recruiting other extracellular proteins, which could result in the 
formation of senile plaques (Citron et al, 1996; Neve et al, 2000). Mutations associated with FAD, 
both APP and presenilin genes (involved in the activity of γ-secretase), carry out an increased Aβ42/ 
Aβ40 ratio (Selkoe, 2002). Aβ molecules can aggregate to form flexible soluble oligomers which may 
exist in several forms. On the other hand, calcium dysregulation has been observed in cells exposed 
to amyloid oligomers. These small aggregates can form ion channels in planar lipid bilayer 
membranes. Channel formation has been hypothesized to account for calcium dysregulation and 
mitochondrial dysfunction by allowing indiscriminate leakage of ions across cell membranes (Kagan 
et al, 2004). Moreover, studies have shown that amyloid deposition is associated with mitochondrial 
dysfunction and it results in the generation of reactive oxygen species (ROS), which can initiate a 
signaling pathway leading to apoptosis (Kadowaki et al, 2005).  
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1.2 Tau & Neurofibrillary tangles  
Tau protein is a microtubule-associated protein (MAP) that under physiological conditions 
regulates microtubules assembly, dynamic behavior, and spatial organization (Drechsel et al, 1992; 
LoPresti et al, 1995). Tau is abundant in neurons of the central nervous system but is also expressed 
at very low levels in astrocytes and oligodendrocytes (Shin et al, 1991). Therefore, modification of 
Tau by phosphorylation or a change in the amount of Tau can result in destabilization of neuronal 
microtubules. This can affect the placement and function of mitochondria, lysosomes, and other 
cellular structures (Avila et al, 2004; Ebneth et al, 1998). Moreover, it is known that autophagosome 
clearance by lysosomes is a microtubule-dependent process (Jahreiss et al, 2008; Matteoni & Kreis, 
1987). Therefore, abnormal function of Tau may disrupt neuronal function including axonal 
transport, which also involves trafficking of autophagic cargos (Yue, 2007)  and lead to the buildup of 
autophagosomes in AD dystrophic neurites or axons (Nixon et al, 2005). 
Neurofibrillary tangles (NFT) are filamentary aggregates of hyperphosphorylated Tau 
protein (Grundke-Iqbal et al, 1986b). It appears within neurons, taking up the perinuclear cytoplasm 
and, after neuronal death, remain in the extracellular space where they are called extracellular 
neurofibrillary or ghost tangles (Braak & Braak, 1991). The NFT are mainly composed by paired 
helical filaments (PHF) and in lower proportion by straight filaments (Hirano et al, 1968). In the 80s, 
the biochemical composition of the PHF was described, composed mainly by the Tau protein 
(Goedert et al, 1988; Grundke-Iqbal et al, 1986a; Kosik et al, 1986; Wischik et al, 1988; Wood et al, 
1986). Further studies revealed that Tau is hyperphosphorylated in the PHF (Grundke-Iqbal et al, 
1986b; Lee et al, 1991; Wolozin et al, 1986). 
2. Mitochondria 
Mitochondria are a double membrane organelle found in most eukaryotic cells. The organelle 
is comprised of two separate and functionally distinct outer and inner membranes that encapsulate 
the intermembrane space and matrix compartments. They also contain a circular genome, 
mitochondrial DNA (mtDNA), that has been reduced during evolution through gene transfer to the 
nucleus. mtDNA is organized into discrete nucleoids in the matrix. 
Mitochondria are cellular energy powerhouses that play important roles in maintaining cell 
survival, cell death and cellular metabolic homeostasis. They perform diverse interconnected 
functions producing ATP and many biosynthetic intermediates while also coordinating cellular stress 
responses such as autophagy and apoptosis (Galluzzi et al, 2012). Mitochondria form a dynamic, 
interconnected network that are intimately integrated with other cellular compartments. In addition, 
mitochondrial functions extend beyond the boundaries of the cell and influence an organism’s 
physiology by regulating communication between cells and tissues. It is therefore not surprising that 
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mitochondrial dysfunction has emerged as a key factor in multiple diseases, including 
neurodegenerative and metabolic disorders.  
2.1 Organization and distribution 
Mitochondria are dynamic organelles that continuously undergo fission and fusion events 
(Fig.1), which are necessary for cell survival as well as adaptation to changing conditions needed for 
cell growth, division, and distribution of mitochondria during differentiation (van der Bliek et al, 
2013). Mitochondrial fusion in mammals is mediated by the fusion proteins mitofusin 1 (Mfn1) and 
mitofusin 2 (Mfn2) and optic atrophy 1 (OPA1) (Ni et al, 2015). Mfn1 and Mfn2 are dynamin-related 
GTPases that are 
responsible for fusion of 
outer mitochondrial 
membranes (OMM). 
OPA1 is also a dynamin-
related GTPase, which is 
responsible for fusion of 
inner mitochondrial 
membranes. Presenilin-
associated rhomboid-
like (PARL) and 
paraplegin (an AAA 
protease family present 
in the mitochondrial matrix) induce alternative splicing and alternative processing of OPA1 to 
generate eight OPA1 isoforms (Cipolat et al, 2006; Ishihara et al, 2006). Mitochondrial fission in 
mammals is mediated by dynamin-like protein 1 (DLP1), which is also a large GTPase (Ni et al, 2015). 
DLP1 is a cytosolic protein that can be recruited to the outer mitochondrial membrane to constrict 
mitochondria resulting in eventual division of a mitochondrion into two separate organelles. DLP1 
interacts with four mitochondrial receptor proteins: fission 1 (Fis1), mitochondria fission factor 
(Mff), mitochondrial dynamics protein of 49 kDa (MID49) and 51kDa (MID51) (Loson et al, 2013; 
Palmer et al, 2011). In mammalian cells, it seems that the interaction between Fis1 and DLP1 has a 
minor role in regulating mitochondrial fission whereas the interactions of DLP1 with the other three 
receptor proteins play prominent roles for fission.  Moreover, during cell division, mitochondrial 
fission is essential for separating mitochondria into two daughter cells.  
In addition to fission and fusion, the movement of mitochondria through the cytoskeleton is 
also important for the cellular distribution and turnover of mitochondria (Mishra & Chan, 2014). 
Mitochondria in mammalian cells are mostly transported on microtubules using a kinesin motor 
towards the plus end and a dynein motor towards the minus end of microtubules (Saxton & 
Figure 1. Scheme of the mitochondrial dynamics. A. Mitochondrial fusion.
B. Mitochondrial fission (Chiong et al, 2014).  
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Hollenbeck, 2012). The attachment of mitochondria to the kinesin motor is regulated by several 
molecular adapters. The adapter protein Milton directly interacts with the outer mitochondrial 
membrane protein Mitochondrial Rho GTPase (Miro) and in turn links mitochondria to kinesin 
(Saxton & Hollenbeck, 2012).  
It has been suggested that mitochondria fission and fusion may serve as important quality 
control mechanisms for preserving mitochondria and are fundamental for the correct distribution of 
the mitochondria in the cell (Detmer & Chan, 2007). This is particularly important for neurons that 
may have very long axons and also for the function of synapses, which are subcellular regions with 
high metabolic requirement (Frazier et al, 2006). Dysfunctional mitochondria may lose their fusion 
capacity by inactivating fusion or activating fission machineries to prevent the damaged 
mitochondria from incorporating back into the healthy mitochondrial network. Daughter 
mitochondria with higher membrane potential (presumably good quality mitochondria) proceed to 
fusion while depolarized daughter mitochondria (presumably bad quality mitochondria) are 
degraded by mitophagy (Twig et al, 2008). On the other hand, although fission plays a pivotal role in 
apoptosis, it has described that inhibition of the mitochondrial fission blocks cell death, resulting in a 
significantly reduced cellular susceptibility toward apoptosis (Frank et al, 2001). 
2.2 Removal of defective mitochondria 
2.2.1 Autophagy 
Autophagy is a stress-induced catabolic process in which components of the cell are 
degraded by the lysosomes (or, in yeast, the analogous vacuole) and recycled (Esclatine et al, 2009; 
Klionsky, 2005). Based on how substrates are delivered to the lysosomal compartment, autophagy is 
classified into three main subtypes: 
 
Chaperone-mediated autophagy (CMA): In CMA, a chaperone protein binds first to its cytosolic 
target substrate and then to a receptor on the lysosomal membrane where the unfolding of the 
protein occurs. The unfolded cytosolic target protein is subsequently translocated directly into the 
lysosome for its degradation (Cuervo, 2010; Massey et al, 2004). 
 
Microautophagy: Microautophagy is a non-selective lysosomal degradative process that 
translocates direct engulfment of cytoplasmic cargo to the lysosome for degradation by either direct 
invagination, protrusion, or septation of the lysosomal membrane (Li et al, 2012). 
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hydrolases. Fusion is an extremely regulated process. Most of the molecular effectors that controls 
fusion process are characterized in yeast but there are some articles which revealed some of the 
proteins involved in fusion in mammal cells such as  Rab7, Rab22 y Rab24 (Ganley et al, 2011) as well 
as proteins of SNARE complex such as Vti1b (Fraldi et al, 2010) and Sintaxin 17 (Itakura et al, 2012). 
The ATP-dependent proton pump V-ATPase ensures low intralysosomal pH, which is essential for 
lysosomal hydrolase activity. Based on studies with the V-ATPase inhibitor Bafilomycin A1, 
lysosomal acidification is also thought to be required for fusion with incoming vesicles from the 
autophagic and endocytic pathways (Wang et al, 2014a). The resulting degradation products are then 
transported back into the cytosol through the activity of membrane permeases for reuse (Klionsky, 
2007). Although macroautophagy is generally considered to be nonspecific, there are many examples 
of selective autophagy, including mitophagy (for mitochondria), ribophagy (for ribosomes), 
pexophagy (for peroxisomes) and reticulophagy (for the endoplasmic reticulum, ER) (He & Klionsky, 
2009).  
Among the three main forms of autophagy, macroautophagy is the most widely studied and 
best characterized process. In this thesis, we will focus on macroautophagy process, referred to as 
autophagy and more specifically in mitophagy.  
2.2.2 Mitophagy 
As it referred previously, mitophagy is the selective degradation 
of mitochondria by autophagy. It often occurs to defective mitochondria following damage or stress. 
It promotes turnover of mitochondria and prevents accumulation of dysfunctional mitochondria 
which can lead to cellular degeneration (Lemasters, 2005). There are two different ways to carry out 
the mitochondrial recycling process.  
 
PARK2-dependent mitophagy: One of the best studied mechanisms for mitophagy in mammalian 
cells is the PINK1–PARK2-mediated mitophagy pathway (Ding & Yin, 2012; Youle & Narendra, 2011). 
The PARK2-dependent mitophagy pathway has been shown to require both PARK2 and PINK1 
proteins. PARK2 RBR E3 ubiquitin protein ligase (PARK2) is a cytosolic E3 ubiquitin l ligase that 
translocates to depolarized mitochondria and initiates their degradation via mitophagy (Narendra et 
al, 2008).  
 
Molecular regulation of PINK1: PTEN induced putative kinase 1 (PINK1) is a mitochondrial 
serine/threonine kinase. Levels of PINK1 are normally undetectable in most cells because PINK1 is 
cleaved in the mitochondria and then degraded by mitochondrial peptidases. However, PINK1 turned 
out to be accumulated in depolarized mitochondria rapidly (Narendra et al, 2010b; Vives-Bauza et al, 
2010), suggesting that PINK1 is subjected to a posttranslational degradation (Fig.3). Several studies 
report that PARL, which is localized in the inner mitochondrial membrane (IMM), processes PINK1 in 
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phospho-ubiquitin activates PARK2 E3 ubiquitin ligase activity through a feed-forward mechanism 
(Kane et al, 2014; Koyano et al, 2014).  
 
PARK2 activation and mitophagy initiation: Once recruited to the mitochondria, PARK2 ubiquitinates 
several mitochondrial outer membrane proteins including the mitochondrial fusion proteins Mfn1 
and Mfn2, Miro, translocase of outer mitochondrial membrane 20 (TOMM20), and voltage-dependent 
anion channel 1 (VDAC1) to initiate mitophagy. Ubiquitination and proteasomal degradation of Mfn1 
and Mfn2 results in mitochondrial  fragmentation. Following PARK2-mediated ubiquitination of 
outer mitochondrial membrane proteins, the selective autophagy adapter protein p62/SQSTM1 
(Sequestosome 1) is recruited to mitochondria and play a role in mitophagy due to its capacity to 
directly interact with LC3 via its LC3 interacting region (Geisler et al, 2010; Huang et al, 2011; Manley 
et al, 2013). However, it seems that the role of p62 in mitophagy is not essential, likely due to the 
presence of other compensatory or redundant similar autophagy receptor proteins (Narendra et al, 
2010a; Okatsu et al, 2010). Interestingly, it was recently found that optineurin, another autophagy 
receptor protein, was also recruited to ubiquitinated mitochondria via its ubiquitin binding domain 
after PARK2 activation on mitochondria. Optineurin induces autophagosome formation around the 
damaged mitochondria by recruiting double FYVE-containing protein 1 and LC3 to damaged 
mitochondria (Wong & Holzbaur, 2014). In addition, PARK2 also recruits Ambra1 (a Beclin-1 
interacting protein) to depolarized mitochondria to initiate engulfment of damaged mitochondria by 
autophagosomes (Van Humbeeck et al, 2011). 
 
PARK2-independent mitophagy: Although the goal of this thesis is focused in PARK2-dependent 
mitophagy is necessary to note that increasing evidence supports that mitophagy can occur 
independent of PARK2. Several autophagy receptor proteins have been shown to localize on 
mitochondria and interact with LC3 to recruit autophagosomes to damaged mitochondria including 
Bcl2/adenovirus E1B 19 kDa protein-interacting protein 3, NIX (also called BNIP3L), Fun14 Domain 
containing 1 besides other mitochondrial E3 ligases such as SMURF1.  
3. Mitochondrial dysfunction & AD 
3.1 Oxidative stress production 
Oxidative stress is a primary event in the development of AD (Bonda et al, 2010a). This 
oxidative stress may be due to the presence of dysfunctional mitochondria resulting in generation of 
reactive oxygen species (ROS) (Santos et al, 2010) that may be toxic for cells with a long life span and 
a deficiency in antioxidant defenses, such as neurons (Moreira et al, 2010). Additionally, 
mitochondria are at the same time a target of ROS causing the oxidation of their components such as 
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quinones (like coenzyme Qo) may facilitate the self-assembly of Tau protein into fibrillar polymers 
similar to those paired helical filaments present in the brain of AD patients (Santa-Maria et al, 2004). 
These findings suggest another possible link between oxidative stress, neuronal dysfunction, and AD.  
It is possible that mitochondrial dysfunction in AD patients not only takes place in the central 
nervous system but also in cells from peripheral tissues. Increased oxidative stress levels and 
reduced antioxidant defenses have been observed in AD fibroblasts (Cecchi et al, 2002). Regarding 
this, it has been described that lipoic acid and N-acetylcysteine may decrease the mitochondrial-
related oxidative stress in Alzheimer disease patients (Moreira et al, 2007a). 
3.2 Mitochondrial dynamics alteration 
Mitochondria failure may arise from a deficient dynamic balance of mitochondrial fission and fusion 
that, in AD (Fig.6), is greatly shifted toward fission and it may result in the presence of dysfunctional 
mitochondria in damaged neurons as well as fibroblasts from AD patients characterized by their 
accumulation into perinuclear areas (Bonda et al, 2010b; Zhu et al, 2013). Vulnerable neurons in AD 
brain exhibit significant reduction in mitochondrial length and increased width with a significant 
increased overall size consistent with unopposed fission suggesting alterations of mitochondrial 
dynamics (Wang et al, 2008b). In agreement with these findings, an abnormal distribution of 
mitochondria was found in pyramidal neurons of AD-affected individuals where mitochondria were 
redistributed away from axons in the pyramidal neurons (Wang et al, 2009). Accordingly, levels of 
fusion proteins OPA1, Mfn1, and Mfn2 were significantly reduced whereas levels of Fis1 were 
significantly increased in AD. In the case of the fission protein DLP1, it has been described a 
reduction in neurons (Bossy et al, 2010; Wang et al, 2008a) and fibroblasts of sporadic patients 
(Wang et al, 2008a). Primary hippocampal neurons treated with Aβ-derived diffusible ligands 
(ADDLs) demonstrated shortened mitochondria in neurons and alteration of fission and fusion 
proteins (Wang et al, 2009). Moreover, time-lapse recordings in these neurons showed impairment 
of both, fission and fusion processes, with fusion process being more severely affected (Wang et al, 
2009). Additional evidence has shown an abnormal interaction of Aβ monomers and oligomers with 
DLP1 that increases with the progression of the disease suggesting a possible cause of abnormal 
mitochondrial dynamics and synaptic damage (Manczak et al, 2011). On the other hand, the 
expression of AD-causing Swedish APP mutation in M17 cells also induced shorter and fatter 
mitochondria, with a slight but significant increase in size, but a decrease in the total mitochondrial 
number while the number of damaged mitochondria was increased (Wang et al, 2008b). Similar 
observations have been found in transgenic mice (Tg2574) harboring the APP Swedish mutation 
(Calkins et al, 2011). Abnormal mitochondrial morphology has been found in fibroblasts from 
sporadic AD patients, where they become significantly elongated and form a highly connected 
network (Wang et al, 2008a). This discrepancy in mitochondrial morphology may be due to 
differences in the expression pattern of proteins involved in dynamics, showing decreased DLP1 and 
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3.3 Relationship between mitochondrial dysfunction and AD-related 
pathology 
3.3.1 Amyloid beta 
In FAD, an increase in the level of Aβ may result in oxidative damage (Belkacemi & 
Ramassamy, 2012; Butterfield, 2002; Schmitt et al, 2012). APP and Aβ accumulate in mitochondrial 
membranes causing structural and functional damage (Pagani & Eckert, 2011). Non-glycosylated full-
length and C-terminal truncated APP has been found to accumulate in the protein import channels of 
mitochondria of human AD brains (Devi et al, 2006) (Fig.6). APP forms stable complexes with the 
translocase of the outer mitochondrial membrane 40 (TOMM40) import channel and the translocase 
of the inner mitochondrial membrane 23 (TIMM23) inhibiting the entry of nuclear-encoded 
cytochrome ܿ oxidase subunits IV and Vb proteins, which was associated with decreased cytochrome 
ܿ oxidase activity and increased ROS production. Additionally, an interaction has been discovered 
between Aβ and phosphorylated Tau with VDAC1 in the brains of AD patients and from APP, 
APP/PSEN1, and 3XTg AD mice which may block the mitochondrial pores leading to mitochondrial 
dysfunction (Manczak & Reddy, 2012).  
Aβ interacts with the mitochondrial protein ABAD (Aβ-binding alcohol dehydrogenase) 
which is upregulated in the temporal lobe of AD patients as well as in APP transgenic mice 
(Lustbader et al, 2004) (Fig.6). This complex prevents the binding of nicotinamide adenine 
dinucleotide NAD to ABAD, thereby changing mitochondrial membrane permeability and reducing 
the activities of respiratory enzymes causing elevated ROS.  
Moreover, it has been suggested that the oxidative stress induced by Aβ may oxidize and 
inactivate presequence protease, PreP, one of the proteins involved in Aβ degradation in the 
mitochondria thus increasing Aβ concentration in mitochondrial matrix and its pathologic effects 
(Alikhani et al, 2009) (Fig.6). 
Aβ has been also involved in alterations of mitochondrial dynamics. In fact, the 
overexpression of human APP Swedish double mutation in neuroblastoma cell lines induces a higher 
percentage of highly fragmented and slower mitochondria correlating with an alteration of the levels 
of the proteins involved in mitochondrial dynamics such as increased fission protein Fis1 and 
reduced levels of fusion proteins like OPA1 and DLP1 (Wang et al, 2008b) (Fig.6). In agreement with 
these in vitro findings, an abnormal distribution of mitochondria was also found in pyramidal 
neurons of AD affected individuals.  
Additionally, Aβ enhances nitrosative stress-inducing S-nitrosylation of DLP1, which favors 
mitochondrial fission followed by mitochondrial depletion from axons and dendrites and 
subsequently synaptic loss (Bossy et al, 2010) (Fig.6). 
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Mitochondrial Aβ may also interact with cyclophilin D, an integral part of the mitochondrial 
permeability transition pore (mPTP), which potentiates free radical production, causes synaptic 
failure, and promotes the opening of the mPTP leading to apoptosis (Du et al, 2008) (Fig.6). 
 On the other hand, Aβ accumulation could result in cytoskeletal aberrations (Kang et al, 
2011) (Fig.6). Aβ oligomers interact with integrins leading to improper control of focal adhesion 
assembly and signaling, therefore causing the dysregulation of cofilin, which is involved in the 
regulation of actin dynamics. The inhibition of actin dynamics is associated with increased ROS 
production and reduced mitochondrial potential. Moreover, cofilin in response to oxidative stress 
translocates to the mitochondria where it induces swelling, a drop in ΔΨm, and cytochrome ܿ release 
promoting the opening of mPTP and apoptosis. 
3.3.2 Presenilin 
Presenilins 1 and 2 are multi-transmembrane proteins associated with nicastrin, APH-1, and 
PEN-2, that form high-molecular ߛ-secretase complex, and are involved in Aβ production by 
intramembrane cleavage of APP. PSEN1 gene mutations are the most prevalent in FAD, but besides 
the generation of Aβ, little is known about its implication in mitochondrial dysfunction and oxidative 
damage. It has been demonstrated that PSEN1 (Ankarcrona & Hultenby, 2002) and PSEN2 are also 
located in mitochondria as part of the ߛ-secretase complex (Hansson et al, 2004). Noteworthy, 
presenilin mutations have been shown to sensitize cells to apoptosis by mechanisms suggested to 
involve impaired mitochondrial function and PSEN2/ߛ-secretase activity can modify ΔΨm 
(Behbahani et al, 2006). Moreover, PSEN2 KO mouse embryonic fibroblasts exhibit lower basal 
respiratory rate. On the other hand, in at least two transgenic mouse models expressing human Tau 
with AD mutations at PSEN1, PSEN1M146L (Schuessel et al, 2006) and PSEN1A246E (Strazielle et al, 
2009), the existence of mitochondrial abnormalities prior to cognitive deficits has been described. 
Also, in the case of PSEN1M146L mice, it was found that the mutation increases mitochondria ROS 
formation and oxidative damage. Finally, it has been recently shown that presenilins and ߛ-secretase 
activities are concentrated in a specialized subcompartment of the endoplasmic reticulum (ER) that 
is physically and biochemically connected to mitochondria, called mitochondria-associated ER 
membranes (MAM) which are involved in mitochondrial function and dynamics, among others (Area-
Gomez et al, 2012; Schon & Area-Gomez, 2010) . Either in presenilin KO mice or fibroblasts from FAD 
and SAD patients, MAM function is increased correlating with a significantly increased area of 
apposition between ER and mitochondria. 
3.3.3 Tau 
Tau is involved in the axonal transport of organelles such as mitochondria (Trinczek et al, 
1999). It is known that Tau-dependent mitochondrial axonal trafficking is regulated by the activity of 
Glycogen synthase kinase 3 beta (Llorens-Martin et al, 2011). Hyperphosphorylated Tau may block 
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the transport of mitochondria leading to energy deprivation and oxidative stress at the synapse as 
well as to neurodegeneration (Stamer et al, 2002) (Fig.6). Analysis of brain proteins from P301L 
mutant human Tau transgenic mice revealed deregulation of mitochondrial respiratory chain 
complex components such as complex V and reduced complex I activity as well as an impaired 
mitochondrial respiration with the subsequent ROS accumulation with aging (David et al, 2005) 
(Fig.5). Accordingly, the overexpression of P301L Tau mutation in human neuroblastoma cells has 
been shown to induce substantial complex I deficit accompanied by decreased ATP levels and 
increased susceptibility to oxidative stress (Schulz et al, 2012). This was paralleled by pronounced 
changes in mitochondrial morphology, decreased fusion and fission rates accompanied by reduced 
expression of OPA1 and DLP1. Moreover, an abnormal interaction of hyperphosphorylated Tau and 
mitochondrial fission protein DLP1 has been described suggesting a relationship with mitochondrial 
dynamics alteration (Manczak et al, 2011) (Fig.6). Other researchers have found that the expression 
of human Tau mutations in both Drosophila (R406W) and mouse neurons (P301L) results in 
elongation of mitochondria, which is accompanied by mitochondrial dysfunction and cell cycle 
mediated cell death (DuBoff et al, 2012). We have previously mentioned an interaction of phospho-
Tau and VDAC1 that may in turn block the mitochondrial pores leading to mitochondrial dysfunction 
(Manczak & Reddy, 2012) (Fig.6). On the other hand, increased oxidative stress has been shown to 
cause Tau hyperphosphorylation in a superoxide dismutase 2 knockout mouse model (Melov et al, 
2007). Furthermore, the inhibition of complex I with annonacin led to a redistribution of Tau from 
the axons to the cell body which correlates with a retrograde transport of mitochondria and finally to 
cell death (Escobar-Khondiker et al, 2007). Lastly, the downregulation of the proteins involved in the 
axonal transport of mitochondria such as Miro and Milton in Drosophila has shown loss of axonal 
mitochondria that promotes Tau phosphorylation in Ser262 via partitioning defective-1 (Drosophila 
homolog of mammalian microtubule affinity-regulating kinase) causing late-onset 
neurodegeneration in the fly (Iijima-Ando et al, 2012). 
3.4 Autophagy and Mitophagy failure 
In AD, Aβ and Tau aggregation has been associated with mitochondrial damage, oxidative 
stress, and cytoskeletal alteration of neurons. Autophagy plays a fundamental role in neuronal 
function and is intensively involved in AD-related protein aggregation (Nixon et al, 2005). Indeed, it 
has been demonstrated that autophagy is the major degradational pathway following unfolded 
protein response activation in neuronal cells, as early event in AD brain, suggesting a connection 
between its activation and the observed autophagic pathology (Scheper et al, 2011). Accordingly, an 
accumulation of autophagic vesicles in the cortex of AD patients compared to non-demented ones has 
been shown (Nixon et al, 2005). Moreover, an increase of autophagic vesicles containing 
mitochondria in pyramidal neurons from AD patients has been found, suggesting a mitophagy 
alteration (Moreira et al, 2007b; Moreira et al, 2007c). According to this, PARK2, as previously 
 
Introduction 
 
26 
 
mentioned, one of the proteins involved in the target of mitochondria to be degraded by mitophagy, 
has been shown to be reduced in the cortex of AD brains (Rosen et al, 2010). Additionally, autophagy 
alterations have been described in AD brain and animal models. Beclin1, a protein that plays a key 
role in autophagy, has been shown to be diminished in the affected brain regions in AD patients early 
in the disease process (Pickford et al, 2008). In the same work, in an APP transgenic mouse model, 
the downregulation or overexpression of Beclin1 increased or diminished, respectively, the Aβ 
accumulation, extracellular Aβ deposition, and neurodegeneration, highlighting the relevance of 
autophagy in AD-related pathology. Moreover, a link between FAD and autophagy has been recently 
indicated (Lee et al, 2010), showing that autophagy requires functional, PSEN1 for lysosomal 
maturation and that is impaired by Alzheimer-related PSEN1 mutations. Thus, PSEN1 mutations 
could indirectly affect mitochondrial function by impairing its recycling by mitophagy. 
On the other hand, autophagy has been proposed to play an active role in AD pathogenesis. In 
this regard, autophagic vesicles have been demonstrated to be an active compartment for Aβ 
generation and their abnormal accumulation in affected neurons of AD brain contributes to Aβ 
deposition (Yu et al, 2004). Additionally, PARK2-induced autophagy facilitated clearance of vesicles 
containing debris and defective mitochondria counteracting oxidative stress and preventing 
mitochondrial dysfunction (Khandelwal et al, 2011). PARK2 reverses intracellular Aβ accumulation 
and its negative effects on proteasome function (Rosen et al, 2010). 
Other strategies for the induction of autophagy as a therapeutic strategy in AD have been 
tested in animal models for the disease. With this aim several molecules have been tested such as 
rapamycin (Caccamo et al, 2010; Spilman et al, 2010), cystatin B (Yang et al, 2011), trehalose 
(Schaeffer et al, 2012), scyllo-Inositol (Lai & McLaurin, 2012), and latrepirdine (Steele & Gandy, 
2013), although effects on improving mitochondrial recycling were not studied in these works. 
4. Models for the study of AD 
 Disease models are indispensable tools for understanding the molecular mechanisms that 
drive pathogenesis and enable the development of novel therapies. As primary patient cells are only  
available in very small quantities, AD studies typically use transgenic animals or transformed cell 
lines. The advantage of animal models is that they can be used to examine a disease in vivo, and 
primary animal cells are easily to isolate in large numbers for applications such as high-throughput 
screening. Transformed cell lines are accessible in large quantities and can be engineered to express 
a disease-causing gene of interest. However, the physiology of animal models and transformed cell 
lines is different from that of patient cells, which may partly explain why sometimes it is difficult to 
recapitulate the features of the disease and why many drug candidates are not effective in patients 
when tested in clinical trials. Therefore, developing these treatments using human models from the 
outset would be a distinct advantage. 
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4.1 Human fibroblasts 
The main advantages of using skin fibroblasts as an in vitro model of AD are their availability 
and robustness. Furthermore, skin fibroblasts represent a model of primary human cells, which 
comprise the chronological and biological aging of the patients according to their polygenic 
predisposition and environmental etiopathology.  
Skin fibroblasts can be easily isolated from 2 mm punch skin biopsies, a procedure which 
does not need stitches and has practically as few complications as a venous puncture (Auburger et al, 
2012). It should be performed by a dermatologist and is not a routine measure in the management of 
AD patients, thus requiring written consent and ethics commission approval.  
The ensuing cell culture is a mixture of primary fibroblasts and keratinocytes at the 
beginning of the culturing process and a pure culture of fibroblasts is only achieved in the third 
passage. However, the fibroblast population consists most probably of a mixture of mitotic and 
postmitotic fibroblast (Auburger et al, 2012), thus contributing to a heterogeneous cell population 
even at early passages. Furthermore, cells may be contaminated with the frequent skin 
microorganism Mycoplasma (Nikfarjam & Farzaneh, 2012), possibly causing deprivation of nutrients, 
reduced growth, inflammatory responses, and oxidative stress, which makes a periodic testing for 
Mycoplasma necessary. Cell propagation, storage of aliquots in liquid nitrogen, and transport are easy 
and comparable to standard cell lines, thus fibroblasts from patients with sporadic AD or familiar AD 
can be obtained from numerous labs and several repositories such as the Coriell Institute in New 
Jersey.   
Since clonal selection and drift in culture are inherent features of fibroblasts, the matching of 
fibroblasts from a sufficient number of patients with their appropriate controls of similar age and sex 
is sometimes an inevitable difficulty.  
In view of the slow growth of primary cells from aged individuals, it needs weeks in culture 
to generate sufficient material for a number of biochemical tests. After some cultivation time, 
primary skin fibroblasts may be similar to mouse embryonic fibroblasts (MEFs) which either 
transform spontaneously or reach replicative senescence, thus altering the previously established 
phenotypes. Therefore, as with all primary cell models, a careful documentation of culture history, 
number of population doublings, and senescence markers such as senescence-activated β-
galactosidase (SA-β-galactosidase) staining are indispensable quality controls. Furthermore, control 
cells and patients fibroblast should have a similar amount of population doublings when comparing 
biochemical or genetic parameters. On the other hand, immortalization of fibroblasts can be regarded 
as an advantage since immortalized cells proliferate faster than primary cells, thus allowing a much 
higher cell yield, and characteristics induced by in vitro aging can be disregarded. A study by 
Sprenger et al. (2010) comparing primary and immortalized fibroblasts shows that both cell types 
are quite similar in the early passages regarding major cell lineage-specific characteristics but 
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expression changes of genes and proteins involved in transcription, cell cycle, receptor tyrosine 
kinase signaling cascade, and in the regulation of the cytoskeleton have been reported (Fridman & 
Tainsky, 2008; Sprenger et al, 2010), indicating that the use of immortalized fibroblast for studies 
involving these pathways must be carefully controlled. Additionally, depending on the immortalizing 
genes combinations used, chromosome instability and tumorigenic transformation may take place 
what may alter genuine properties of the cell (Garcia-Escudero et al, 2010). 
Primary skin fibroblasts are a suitable extraneural model for neurodegenerative diseases 
because it has been described that these cells are able to reflect cumulative cell damage at the age of 
the patient. The can be obtained from living patients giving the possibility of benefiting the individual 
with the findings. Additionally, it can be reprogrammed to induced pluripotent stem cells (iPSC) and 
differentiated to various types of neurons as a human neuronal in vitro model of AD. However, it has 
to be kept in mind that fibroblasts are quite resistant against most stressors as well as their gene 
expression profile and their signaling could differ from neurons.  
Althought work with human fibroblasts exhibits the disadvantages explain before, they are a 
powerful source for the study of AD and an excellent tool to develop a model of the pathology.   
4.2 Induced pluripotent stem cells and iPSC-derived neurons  
4.2.1 Induced pluripotent stem cell technology 
The discovery that somatic cells could be reprogrammed to a pluripotent state has 
profoundly altered the landscape in which stem cell research is conducted. A revolutionary work in 
2006 by Takahashi and Yamanaka demonstrated for the first time that adult differentiated cells such 
as fibroblasts are able to be retrodifferentiated to generate stem cells (Takahashi & Yamanaka, 
2006). Four transcriptions factors, Oct4, Sox2, c-Myc, and Klf4, were enough to induce pluripotency 
in primary fibroblast indicating that cell programming could be reversed. Other groups have 
generated similarly pluripotent cells from other peripheral cells, such as blood cells (Loh et al, 2009) 
keratinocytes (Aasen et al, 2008), B lymphocytes (Hanna et al, 2008), neural stem cells (Kim et al, 
2008a) or hepatocytes (Stadtfeld et al, 2008). It is important to keep in mind that exogenous factors, 
genetic background, and epigenetic of tissue origin of cells influences native pluripotency (Hanna et 
al, 2010). Therefore certain differences on the epigenetic landscape are expected to exist between ES 
and iPS cells (Bock et al, 2011; Lister et al, 2011). 
Patient-specific iPSCs are well suited for generating human disease models. In theory, the 
limitless self-renewal and differentiation properties of iPSCs enable them to produce the large 
quantities of specific cell types for basic research and drug discovery. iPSC technology offers a unique 
tool to dissect the principles of cell fate determination during normal development and its 
dysregulation in disease (Stadtfeld & Hochedlinger, 2010). The abundance of studies clearly shows 
that iPSCs are a reliable tool for disease modelling. One advantage of using iPSCs derived from 
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patients with highly penetrant mutations is that these cells are likely to recapitulate disease 
phenotypes; indeed, the vast majority of disease models generated so far are from genetic mutations 
that cause disease in a Mendelian manner. However, most diseases are either sporadic or the result 
of polymorphisms at multiple loci. The alternative approach for modelling diseases using iPSCs from 
patients with a risk allele or a sporadic disease has been extremely challenging. Unlike conventional 
models, a great advantage of iPSCs is that they are derived from individual patients with observable 
phenotypes, even when there are multiple unknown contributing genetic mutations.  
The study of human brain disorderes is hampered by obtaining live material relevant for the 
disease. The ability to generate neural cultures from post-mortem human brains depends greatly on 
the quality of the post-mortem brain tissue (Verwer et al, 2002) but in most cases is extremely 
difficult. The generation of human iPS cells is one way to surmount these limitations. Protocols have 
been developed to differentiate iPS cells in vitro into distinct neuronal types allowing researchers to 
examine disease onset and progression directly in different models of neurological disorders (Liu et 
al, 2012; Sandoe & Eggan, 2013).  
4.2.2 iPSC differentiation into neural subtypes relevant to AD 
Several groups have succeeded in creating functional neurons from FAD and SAD iPSC that 
recapitulates the features of AD pathology (Table 1). The base protocols used for these 
differentiations include dual-SMAD inhibition in a monolayer culture (Chambers et al, 2009), an 
embryoid body or aggregate method (Eiraku et al, 2008) or more recently, the formation of cerebral 
organoids (Lancaster et al, 2013).  
Both glutamatergic and GABAergic neuronal fates have been implicated in different aspects 
of AD pathogenesis. Through modulation of patterning pathways, differentiation can be directed to 
generate cultures of more dorsal, glutamatergic fates (Vazin et al, 2014; Zeng et al, 2010) or else of 
more ventral, GABAergic fates (Cunningham et al, 2014; Nicholas et al, 2013). It was recently shown 
that iPSC-derived GABAergic neurons are less susceptible to Aβ induced cell death (Vazin et al, 
2014), thus demonstrating the differential phenotypes that can be understood by specifying cell 
fates.  
The loss of basal forebrain cholinergic neurons is associated with deficits in spatial learning 
and memory in AD pathology. Since cholinergic neurons are among the first to degenerate in AD, 
there has been much interest in directing differentiation to this fate. Cholinergic neurons can be 
generated from human ES cells by sequential treatment with growth factors that are found in the 
forebrain during different developmental stages (Bissonnette et al, 2011). Alternatively, cholinergic 
neurons can be generated by the overexpression of transcription factors. Expression of Lhx8 and 
Gbx1 is necessary and sufficient to generate basal forebrain cholinergic neurons (Bissonnette et al, 
2011). Production of cholinergic neurons by nucleofection with Lhx8/Gbx1-IRES-GFP allows for 
additional purification of cell populations by fluorescence-activated cell sorting. iPSC-derived basal 
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forebrain cholinergic neurons originated from sporadic AD patients of the apoE3/E4 background 
using this method displayed typical AD biochemical features including an increase in the Aβ42 to 
Aβ40 ratio and an augmented vulnerability to glutamate-mediated cell death (Duan et al, 2014). 
 
 
AD 
lines 
Description 
Sp
or
di
c 
Oligomerization of Aβ, endoplasmic reticulum and oxidative stress (Kondo et al, 2013) 
Increased secretion of Aβ40, phosphorylation of Tau, activation of GSK3β, large and very early endosomes 
(Israel et al, 2012) 
Effect of BDNF on Aβ secretion is SORL1 gene-dependent (Young et al, 2015)    
AP
P 
D
om
in
an
t 
m
ut
at
io
n 
Increased secretion of Aβ40, phosphorylation of Tau, activation of GSK3β, large and very early
endosomes (Israel et al, 2012) 
Abundance of intracellular Aβ oligomers, increased Aβ42/Aβ40 ratio (Kondo et al, 2013)
Increased Aβ42/Aβ40 ratio (Mertens et al, 2013)
Increased β-secretase cleavage of APP, altered γ-secretase cleavage, increased Aβ42, 
increased phospho-Tau (Muratore et al, 2014) 
Elevation of intracellular tau protein levels (Moore et al, 2015)
Re
c.
 
m
ut
 Decreased secretion of Aβ40,  increased oligomerization of Aβ, increased stress response 
(Kondo et al, 2013) 
PS
EN
1/
PS
EN
2 PSEN1A79V Increased Aβ42/Aβ40 ratio (Mertens et al, 2013)
PSEN1L166P Increase Aβ42/40 ratio, selective decrease in Aβ40 production (Koch et al, 2012) 
 
PSEN1A246E 
PSEN1M146L 
Increased Aβ42/Aβ40 ratio (Mahairaki et al, 2014; Sproul et al, 2014; Yagi et al, 2011)
14 genes differentially regulated in FAD lines. Five of these genes were differentially 
expressed in brains of late and intermediate AD patients (Sproul et al, 2014) 
PSEN2N141 Increase in Aβ42 secretion (Yagi et al, 2011)
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Summary of published works using human iPSC models of AD.  
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Mitochondrial dysfunction and oxidative damage play a critical role in the pathogenesis of 
Alzheimer disease. Accumulation of oxidatively damaged proteins and organelles due to inefficient 
degradation could exacerbate the pathophysiology of the cell in this disorder. It is well known the 
fundamental function of autophagy in AD related proteopathy. Moreover, autophagy alterations have 
been described in Alzheimer disease mouse models and patients’ samples. 
By generating different human cellular models of Alzheimer disease we propose the 
following objectives: 
 
1. Study of APP and Tau contribution to autophagy and mitochondrial recycling process.  
 
2. Study of autophagy and mitophagy system in the early onset familial form of Alzheimer 
disease through: 
 
• a cell model of skin fibroblasts derived from FAD patients. 
 
• validation of the anomalies found in fibroblasts in a neural model derived from iPSC 
from FAD patients.  
 
3. Study of mitochondrial function, autophagy and mitochondrial recycling process in the late 
onset sporadic form of Alzheimer disease through: 
 
• a cell model of skin fibroblasts derived from SAD patients. 
 
• validation of the anomalies found in fibroblasts in brain samples from AD patients.  
 
4. Study of autophagy enhancement as a therapeutic strategy in SAD patients.  
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1. Materials 
  1.2 Primary cells 
Primary skin fibroblasts from AD patients and their correspondent healthy sex and age-
matched samples were obtained from Coriell Institute for Medical Research (New Jersey, USA). iPSC 
lines were generated by Andrew Sproul from New York Stem Cell Foundation from fibroblast cell 
lines AG06842 and AG07671. See Table 2 for details about age, sex and stage of the disease of these 
cells.  
1.3 Brain tissues 
Hippocampal brain samples from SAD patients and control subjects were obtained from 
Banco de Tejidos (Fundación CIEN, Instituto de Salud Carlos III, Madrid, Spain). On the basis of 
quantitative pathological features, the SAD brain specimens were classified (Table 3) as coming from 
SAD patients at Braak stages II and III (early AD) (n=5),  Braak stage V (n=5) and Braak VI (n=6) 
(severe AD),  and control subjects (n=6). Written informed consent was obtained from all the 
patients.  
 
 
  
Table 3. Brain samples. 
Table 2. Brain samples.
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Table 4. Antibodies used in this work.
1/500
 
Materials and Methods 
 
39 
 
1.1 Antibodies 
The primary antibodies used in this work for Western Blot and immunostaining are listed in 
the following Table 4.  
For Western Blot analysis the following HRP (horseradish peroxidase) conjugated secondary 
antibodies were used: anti-mouse, anti- rabbit (DAKO) all produced in goat at 1/1000 dilution. For 
immunostaining assays the following Alexa secondary conjugated antibodies were used: anti-mouse, 
anti- rabbit and anti-goat Alexa 488/555/647 (Invitrogen) all produced in donkey at 1/1000 
dilution. To nucleic acid staining, 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) was used.  
2. Methods 
2.1 Cell culture methods 
2.1.1 Fibroblasts culture conditions  
Human fibroblasts were cultured in Dulbecco´s modified Eagle´s medium (DMEM) 
supplemented with 10% (v/v) heat-inactivated Fetal Bovine Serum (FBS), 2 mM glutamine, 10 U/ml 
penicillin, 10 μg/ml streptomycin, in 5% CO2 in a humid incubator at 37oC. The use of fibroblasts has 
been restricted to a maximum of 10 cell passages to avoid replicative senescence and cultures were 
always kept below confluence.  
2.1.2 iPSC culture conditions  
Undifferentiated iPSCs were kept onto Cultrex (Trevigen, 3432-005-01)-coated dishes and 
grown in feeder-free maintenance basal medium for hESCs and hiPSCs mTesR1 (StemCell 
Technologies, 05851) supplemented with mTeSR1 5X Supplement (StemCell Technologies, 05852) 
contained penicillin-streptomycin (100U/mL-0.1mg/mL) in 5% CO2 in a humid incubator at 37oC.  
2.1.3 Retroviral reprogramming 
Fibroblasts were plated at 3x104– 5x104 cells in a single well of a 6-well plate or multiple 
wells of a 12- well-plate, which was infected the 6-18 hours later with four retroviruses prepared for 
Oct4, KLF4, Sox2, and c-Myc by the Harvard Gene Therapy Core (Sproul et al, 2014). Infected 
fibroblasts were split 7-14 days post-infection onto MEFs (γ-irradiated mouse embryonic fibroblasts) 
and concomitantly treated with three chemical compounds to enhance reprogramming: SB431512 (2 
μM), Thiazovivan (0.5 μM), and PD0325901 (0.5 μM) (Lin et al, 2009). iPSC colonies were initially 
selected by morphology, passaged several times to remove untransformed cells, and expanded 
before characterization. 
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2.1.4 Monolayer neuronal cortical differentiation 
iPSC colonies were dissociated into single cells by washing with PBS and adding 1 ml 
Accutase (Life Technologies, A1110501) and then plated onto Cultrex-coated dishes in mTesR1 
medium containing 10 μM ROCK inhibitor (Y-27632, Stemgent, 04-0012). Cells were plated at a 
density of 3x105 cells per 6 well-plate and allowed to recover for 3 days to allow near confluency. 
Cells were neuronally differentiated with dual-smad inhibition from days 0-9 in custom TesR1 (5x 
supplement W/o 5 factors mTesR1 and penicillin-streptomycin (100 U/mL-0.1 mg/mL)) using 10 
μM SB431542 (Stemgent, 04-0010) and 250 nM LDN193189 (Stemgent, 04-0074). Cell were split 
with Accutase (Life Technologies, A1110501) on day 10 and plated at a density of 2x105 cells per 6 
well-plate on 100μg/mL Poly-L-Ornithine (Sigma-Aldrich, P3655)/ 3 μg/mL laminin plates. 
Monolayer neuronal differentiation was carried out in Neurobasal (Life Technologies, 21103049) + 
B27 supplement (Life Technologies, 17504044) and cells were fed every 2 to 3 days until analyzed. 
At day 30, neuronal differentiation media was supplemented with 20 ng/ml BDNF (R&D system, 
2837).  
2.1.5 Lentivirus production 
Pseudotyped lentivectors were produced using reagents and protocols from Didier Trono 
with the following modifications: 293T cells were transiently co-transfected with 5 μg of the 
corresponding lentivector plasmid, 5 μg of the packaging plasmid pCMVdR8.74 (Addgene plasmid 
22036) and 2 μg of the VSV G envelope protein plasmid pMD2G (Addgene plasmid 12259) using 
Lipofectamine and Plus reagents following instructions of the supplier (18324 and 11514, 
respectively, Life Techonologies). The lentivector used encodes wild type PARK2, and was a gift from 
Dr. Andrew B. West (University of Alabama) (da Costa et al, 2009). 
2.2 Biochemistry methods 
2.2.1 Western Blot analysis 
The cells and tissue samples were homogenized in lysis buffer (50 mM pH 7.5 HCl-Tris, 300 
mM NaCl, 0.5% SDS and 1% Triton X-100) and incubated 15 min at 95ºC. Protein concentration of 
the extracts was measured using the Dc protein assay kit (500-0111, Bio-Rad). Equal amounts of 
total protein extract from healthy and SAD cells were resolved by SDS-PAGE and then transferred to 
nitrocellulose membranes (G9917809, Amersham, Germany). Western blot and immunoreactive 
proteins were developed using an enhanced chemiluminescence detection kit (NEL105001EA, Perkin 
Elmer) following instructions of the supplier. Quantification was performed by densitometry of the 
obtained bands in each lane with respect to the correspondent housekeeping protein in each 
experiment (Quantity One software, Bio-Rad). When several paired samples were compared very 
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data was normalized with respect to the values obtained from each correspondent age-matched 
healthy sample. 
2.2.2 Protein oxidation detection 
OxyBlot Protein Oxidation Detection Kit (S7150, Millipore) was used to detect oxidized 
proteins in cell extracts using the supplier guidelines. Briefly stated, carbonyl groups of cell extract 
proteins were treated with 2,4-dinitrophenylhydrazine. Equal amounts of total protein extract (20 
μg) were loaded and Western blot detection was performed as previously described. Quantification 
was done by densitometry of the obtained bands in each lane (Quantity One software, Bio-Rad) with 
respect to GAPDH signal and every result was normalized with respect to the values obtained from 
each correspondent age-matched healthy sample. 
2.2.3 Ubiquitination levels detection 
A conventional Western blot was performed as described above by using the primary 
antibody against ubiquitin motive (Z0458, Dako). Quantification was performed by densitometry of 
each lane (Quantity One software, Bio-Rad) with respect to the correspondent GADPH signal and 
every result was normalized with respect to the correspondent age-matched healthy sample. 
2.2.4 Mitochondrial isolation 
The Mitochondria Isolation Kit for Mammalian Cells (89874, Pierce Protein Biology Products) 
was used to isolate intact mitochondria from cultured cells using the manufacturer´s protocol. 
2.2.5 Phos-tag assay 
Cells were treated with 20 μM CCCP for 1 h and then lysed in Western blot lysis buffer. We 
use 7.5% polyacrylamide gels containing 50 μM Phos-tag acrylamide AAL-107 (Wako chemicals) and 
100 μM MnCl2. After electrophoresis, gels were washed twice with transfer buffer containing 0.01% 
SDS and 10 mM EDTA for 20 min, and then replaced with transfer buffer containing 0.01% SDS for 10 
min. Proteins were transferred to PVDF membranes and analyzed by conventional immunoblotting. 
For dephosphorylation, extracts treated with CCCP were incubated for 1 h with 800 U of lambda 
protein phosphatase (λPP, Sigma, St. Louis Missouri) following the guidelines of the supplier. 
2.3 Molecular biology methods 
2.3.1 Pluripotency and differentiation score analysis 
To ensure that non-reprogrammed or partially reprogrammed fibroblast lines were 
distinguished from successfully reprogrammed iPSC lines, gene expression signatures were used to 
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measure the pluripotency and differentiation score. Assays were carried out by the NanoString 
protocol. Samples of 105cells were lysed and RNA hybridized to custom specific molecularly-
barcoded reporter and capture probes before processing on the nCounter Prep-station (NanoString). 
Processed samples were then loaded into an nCounter Digital Analyzer (NanoString) and scanned at 
high resolution (about 800 frames/sample). nCounter Analyzer data were analyzed on NanoString’s 
nSolver software, normalizing counts to three housekeeping genes, ACTB, POLR2A, and ALAS1. Probe 
sets include a Pluripotency Codeset of 25 genes indicative of pluripotency and a Lineage Codeset 
including multiple targets indicative of separate germ layers previously described (Kahler et al, 
2013).  
2.3.2 Quantitative real-time PCR assays 
Frozen brain tissue was homogenized using a TissueLyser (Retsch MM300, Qiagen, GmbH, 
Hilden, Germany) run at 30 Hz for 5 min with 5 mm stainless steel beads (69989, Qiagen) in 700 μl of 
QIAzol Lysis Reagent (79306, Qiagen). RNA was extracted using miRNeasy Mini Kit (217004, Qiagen) 
with RNase-Free DNase Set (79254, Qiagen) following provider’s guidelines. RNA integrity number 
(RIN) of each sample was calculated using the Agilent 2100 Bioanalyzer system (Agilent 
Technologies) and only RNAs with RIN above 5 were used for RT-qPCR. Retrotranscription was 
performed with Transcriptor First Strand cDNA Synthesis Kit (04379012001, Roche) using 20 ng/μl 
of RNA with random primers. Quantitative PCR was performed in a thermocycler AB7.900HT 
(Applied Biosystems) using the following conditions: 50ºC for 2 min, 95ºC for 10 min and 40 cycles of 
95ºC for 15 sec. and 60ºC for 1 min. The oligos used for the detection were PARK2-F: 
CCCTGGGACTAGTGCAGAAT, PARK2-R: TGCGATCAGGTGCAAAGCTA, PINK1-F: 
CATGCCTACATTGCCCCAGA, PINK1-R: GAACCTGCCGAGATGTTCCA, TOMM20-F: 
GCTGGGCTTTCCAAGTTACC, TOMM20-R: AGTAACTGCTGTGGCTGTCC, MTRNR2-F: 
CGATGGTGCAGCCGCTATTA, and MTRNR2-R: ATCATTTACGGGGGAAGGCG. Genes expression were 
normalized to GAPDH expression using TaqMan primer human GAPDH (Hs99999905_m1, Applied 
Biosystems).  
2.3.3 Microarray analysis 
The expression profiling by array (Affymetrix  Human Gene 1.0 ST Array) of PARK2, PINK1 
and TOMM20 of human brain samples classified into healthy (n=47) vs AD (n=32) was retrieved from 
the Hisayama study (Hokama et al, 2014). Differences in PARK2, PINK1 and TOMM20 expression 
between healthy and AD were calculated using Student’s T test.   
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2.4 Functional study methods 
2.4.1 MTT assay 
Cells were grown in 96-well plates and treated as indicated. Metabolic status was determined 
by 200 μg/ml MTT (3-[4,5-dimethylthiazo-2-yl]-2,5-diphenyltetrazolium bromide) (Sigma, M2128) 
as previously described (Mosmann, 1983). 
2.4.2 Mitochondrial dynamics study  
Cells were infected at an approximate MOI: 5-10 with a lentivector encoding DsRed2-Mito 
construct obtained from Clontech (632421) kindly provided by Dr. Ismael Santa-María. Cells were 
treated with CCCP (20 µM, Sigma, St. Louis Missouri) for 6 h and, in the reversible condition, CCCP 
was removed after 1 h and the medium was replaced for DMEM 10% FCS. After the treatments cells 
were fixed with 4% PFA and mitochondrial pattern was observed with a Radiance 2000 confocal 
system (Bio-Rad) coupled to an Axiovert S100 TV inverted microscope (Zeiss). 10 randomly chosen 
fields containing between 10 and 15 cells were used to quantify the pattern of mitochondria 
distinguishing between completely filamentous (long and spaghetti-like shape), fragmentated 
(completely punctated) and intermediate pattern (when both filamentous and punctated 
mitochondria were found). 
2.4.3 Mitochondrial potential measurement 
Cells were treated with 20 μM carbonyl cyanide m-chlorophenylhydrazone (CCCP; C2759, 
Sigma) for 7 h and, in the reversible condition, CCCP was removed and the medium was replaced for 
DMEM 10% FBS during the last 60 min. Then, fibroblasts were incubated with 50 nM DiOC6(3) 
(D273, Molecular Probes) for 30 min at 37 ºC and analyzed by flow cytometry (FACSCalibur, BD 
Biosciences, San Jose, CA). Mitochondrial membrane potential for each condition was represented as 
the percentage of the fluorescence intensity with respect to fluorescence intensity exhibited when 
these cells remained untreated. 
2.4.4 ATP quantification 
ATP was quantified using ATP determination kit (Invitrogen). After correspondent 
treatments, cell extracts were prepared in PBS 0.5% triton X-100 and, following the manufacturer’s 
instructions, ATP content was determined by luminiscence using a FLUOstar OPTIMA Plate Reader 
(BMG Labtech) at 28ºC, using Costar 96-well black plates (Fisher Scientific). As a control we used 
Oligomycin 10 μM for 1 h (O4876, Sigma). 
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2.4.5 Autophagy flux study  
Fibroblasts and iPSC-derived neurons were treated with CCCP (20 μM) for 24h followed by an 
additional treatment of PBS or NH4Cl (15 mM) for 6h in the presence of CCCP. After the treatment, cells 
were lysed in Western blot buffer and immunodetection of autophagy involved proteins was performed 
as described in Methods 2.2.1. Quantification of autophagic synthesis was represented as the ratio 
between the values of the cells trated with CCCP and NH4Cl with respect to the condition without CCCP 
but maintaining NH4Cl treatmnt. Quantification of autophagic degradation ratio was obtained by the 
relation between the values of the cells treated with CCCP and NH4Cl and the ones without NH4Cl but 
maintaining CCCP treatment according to autophagy standard guidelines (Klionsky et al, 2016). 
2.4.6 Lysosomal function study 
Cells were treated with 100 nM bafilomycin A1 (B1793, Sigma) for 2 h or remain untreated. 
After that, cells were collected and treated with 500 nM LysoTracker Red DND-99 (L-7528, Molecular 
Probes, Life Technologies) for 20 min. Then, cells were analyzed by flow cytometry (FACSCalibur, BD 
Biosciences, San Jose, CA). Relative LysoTracker level represents the ratio of the FL-2 fluorescence 
intensity of the untreated condition and the bafilomycin treated one. 
2.4.7 Cathepsin assay (Magic Red) 
Fibroblasts were plated to chambered coverglasses and imaged the following day on FRET in 
vivo Imaging System (Zeiss, Oberkochen, Germany) coupled to an Axiovert200 microscope (Zeiss). At 
the start of imaging, Magic Red reagent (937, Immunochemistry Technologies) was diluted 1:365 
into PBS, and then this solution was added at a 1:10 dilution into the cell culture media. Images were 
acquired using a 20X Plan-Apochromat objective (420650-9901-000, Zeiss); numerical aperture of 
0.6, at 4 min intervals for a total of 32 min. Image analysis was performed using ImageJ software 
(Bethesda, MD). Images were thresholded to include only the lysosomal compartment, using the 
same numerical threshold for all images across a single experiment. The total fluorescence above 
threshold was normalized to the total area of the lysosomal compartment, measured as the area 
above threshold at t = 32 min. Graph represents means and standard deviation of normalized 
fluorescence intensities plotted over time obtained from three Alzheimer and healthy couples.  
2.5 Immunochemistry methods 
2.5.1 Immunocytochemistry  
Fibroblasts and differentiated neurons were grown on sterile glass coverslips, treated as 
described for each experiment, followed by washing with PBS and fixing with 4% paraformaldehyde 
in PBS for 30 min or 10 min for fibroblasts or neurons respectively at room temperature. After 
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blocking with PBS containing 1% BSA, permeabilizing with 0.1% Triton X-100 and Glycine 1 M for 30 
minutes, cells were washed with PBS and stained by indirect immunofluorescence using the 
antibodies described before. When indicated, phalloidin (A-12379, Life Techonolgies) was added at 
1:200 during the second antibody incubation. Samples were mounted with Prolong Gold Antifade (P-
36930, Life Technologies) and randomly chosen field images were obtained in an Invert Confocal 
LSM510 (Zeiss, Oberkochen, Germany) fluorescence microscope. iPSC colonies were fixed with 4% 
for 10 minutes and blocked with blocking buffer (PBS with 0.25% TritonX-100, 2% bovine serum 
albumin, and 1% sodium azide) for 30 minutes. Cells were then stained with primary antibody 
diluted according to manufacturer recommendation in blocking buffer overnight at 4°C. Cells were 
washed with 0.1% PBS and stained with secondary antibody (1:400 in blocking buffer) for two hours 
at room temperature. Cells were washed again with 0.1% PBS and images were taken on an Olympus 
IX71 inverted microscope.  
2.5.2 Mitochondrial content analysis 
Mitochondrial content was measured by ImageJ macro designed by Ruben K. Dagda at the 
University of Pittsburgh (Dagda et al, 2009). The macro allows to threshold immunostained 
mitochondria in cells labeled with a mitochondrial antibody or transiently expressing 
mitochondrially targeted GFP. This macro displays measurements of several mitochondrial 
parameters such as mitochondrial count, total mitochondrial area or mitochondrial perimeter. 
Briefly, the macro splits the channels and the image with mitochondria is automatically thresholded. 
The next step of the macro consists in analyzing the different mitochondrial parameters drawing 
individual outlines for each mitochondrion. Then, the program displays a panel with the parameters 
measured. In our case, we used the total area of all mitochondria measured. 
2.5.3 Autophagolysosomes quantification 
Fibroblasts were transfected with mRFP-GFP tandem fluorescent-tagged LC3 plasmid 
(Kimura et al, 2007) using Polyethylenimine (PEI; 408727, Sigma). After 24 h, cells were fixed and 
processed for analysis in an Invert Confocal LSM510 (Zeiss, Oberkochen, Germany) fluorescence 
microscope. Quantification of only RFP-positive dots per cell was performed with ImageJ software 
(Bethesda, MD). 
2.5.4 Colocalization assay 
Colocalization analysis was performed with ImageJ software (Bethesda, MD) and every cell 
was manually delimited according to phalloidin staining. The background of different channels was 
edited with Subtract Background tool with a rolling ball radius of 30 pixels; and by a threshold 
intensity, binary images were obtained. The logical operation AND of the Image Calculator tool was 
used to generate an image harboring only overlapping structures of both channels. Colocalization 
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measurement was obtained by quantifying the area occupied by the overlapping elements per cell. At 
least 200 cells were measured for each cell line. 
2.6 Statistical analysis 
When paired samples were used, values represented in the graphs were obtained by 
normalizing every AD sample data with its correspondent age-matched healthy sample. Randomly 
chosen AD-healthy couples were used for each experiment without any specific exclusion criteria. 
Graphs represent means and standard deviations of the values obtained from experimental 
triplicates or from at least three SAD-healthy couples. Statistical comparison of the data sets was 
performed by the Student’s t test. Two-way ANOVA test was performed to examine the differences 
between experimental factors and their interaction. A post hoc Bonferroni test was used when more 
than two experimental groups were compared. When the distribution of the data was not normal a 
nonparametric Mann–Whitney U test was used. The differences are given with their corresponding 
statistical significance or p value, which is the probability that the difference occurred merely by 
chance under the null hypothesis. 
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of Aβ from amyloid precursor protein (APP), which is produced in the brain and other tissues (Haass, 
1993 (Haass & Selkoe, 1993), (Thinakaran & Koo, 2008).  
 Over 180 mutations in PSEN1 have been reported as the cause of early onset Alzheimer 
disease (Cruts et al, 2012). Defective Presenilin 1 interferes with the function of the γ-secretase 
complex, which alters the processing of APP and leads to the overproduction of a longer, toxic 
version of Aβ peptide (Aβ42) (Borchelt et al, 1996). Generation of toxic Aβ peptide and the formation 
of amyloid plaques likely lead to the death of neurons and the progressive signs and symptoms of 
this disorder. To develop this work we have focused in the PSEN1 Ala246Glu mutation known as 
FAD1. This mutation was originally reported in 1995 in conjunction with the cloning of the PSEN1 
gene (Sherrington et al, 1995). It was detected in a Canadian family of Anglo Saxon-Celtic origin. The 
pattern of transmission is consistent with autosomal-dominant inheritance, and genetic analysis 
confirmed that the mutation segregated with disease.  
Besides the generation of Aβ, little is known about PSEN1 implication in mitochondrial 
dysfunction and oxidative damage. Previous study defined an essential role for PSEN1 in the 
maturation and trafficking of the v-ATPase responsible for lysosome acidification which is essential 
for the normal turnover of proteins and organelles by autophagy (Lee et al, 2010). Taking into 
account these data, the next goal of this work is the evaluation of mitochondrial recycling process by 
autophagy in two different human cell models of AD -associated PSEN1 mutations, unmodified skin 
fibroblasts and iPSC-derived neurons.  
2.1 Study of mitochondrial recycling process in fibroblasts from 
patients harboring AD-associated PSEN1 mutation.  
To achieve the first part of this project, we used human primary cell lines of skin fibroblasts 
from FAD patients obtained from Coriell Institute (Table 2) carrying the mutation FAD1: PSEN1 
Ala246Glu compared to their correspondent age- and sex-matched samples from non-demented 
individuals.  
2.1.1 Autophagy degradation impairment in PSEN1-FAD fibroblasts.  
To identify whether autophagy may be altered in our PSEN1-FAD (FAD1) fibroblasts, as it 
was previously published (Lee et al, 2010), we treated the cells with CCCP for 24h followed by an 
additional treatment of NH4Cl for 6h in the presence of CCCP to block the degradation phase of 
autophagy. As expected, Western blot analysis revealed an increase of LC3II and LC3II/LC3I ratio 
levels in FAD1 fibroblasts compared to healthy samples, being more significance the second one (Fig. 
18A-B). This may reflect an accumulation of autophagic vesicles in FAD1 cells. According to this, we 
could observe a diminished autophagy flux where the autophagosome (LC3II) synthesis was slightly 
decreased but the degradation was drastically reduced in FAD1 samples (Fig. 18C-D). These data 
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3. Mitophagy study in a model of sporadic Alzheimer 
disease.  
The majority of AD cases have a sporadic etiology, in which the disease could arise through 
interactions among various genetic and environmental risk factors that potentially contribute to the 
pathology development (Stozicka et al, 2007). The leading AD molecular paradigm, the “amyloid 
cascade hypothesis”, is based on studies of rare autosomal dominant variants and does not represent 
what initiates the most common late-onset sporadic form. It has been proposed for SAD a 
“mitochondrial cascade hypothesis” that posits mitochondrial dysfunction as primary pathology and 
comprehensively reconciles seemingly histopathologic and pathophysiologic features (Swerdlow & 
Khan, 2004).  
Sporadic disease models are indispensable tools for understanding the molecular 
mechanisms that drive pathogenesis and enable the development of novel therapies. Although our 
ability to model diseases in mice is improving rapidly, owing to the advent of sophisticated molecular 
tools, sporadic diseases usually have a much more complex pathogenesis that can be difficult to 
model accurately. Therefore, search and study of SAD in a human model is the key to decipher the 
mechanisms underlying the pathology.  
Taking into account these premises, the next step of this thesis consisted in the study of a 
possible impairment in the mitochondrial recycling in a human unmodified cell model of SAD that 
could support the important role of mitochondria in late-onset AD.  
3.1 Study of mitochondrial recycling process in fibroblasts from 
sporadic AD patients. 
Human fibroblast cell culture systems have been used to model both molecular events 
associated with the aging process and the biochemical anomalies found in AD. Our first goal was to 
evaluate the autophagy-mitophagy system function in human primary cell line of skin fibroblasts 
from SAD patients obtained from Coriell Institute as well as their correspondent age-matched 
healthy samples (Table 2).  
3.1.1 Mitochondrial anomalies in SAD fibroblasts 
Consistent with previous findings demonstrating increased ROS levels in familial AD 
fibroblasts (Naderi et al, 2006), we analyzed oxidation of proteins in fibroblasts from SAD patients 
compared with its correspondent age-matched healthy samples. Through OxyBlot analysis we 
observed that SAD cells showed an increased amount of oxidized proteins under basal conditions 
(Fig. 37). Abnormal mitochondrial distribution and morphology has been described in SAD fibro- 
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We next analyzed a putative improvement of autophagy process after PARK2 overexpression. 
In fact we could observe a restauration of the basal levels of AVs in SAD samples what was shown in 
the increase of LC3II protein levels up to the ones observed in healthy samples (Fig. 57A-B). 
However, the induction of AVs represented by the LC3II/LC3I ratio, were not significantly increased 
(Fig. 57C). Noteworthy, we also could observe a significant improvement of AV synthesis (Fig. 57D). 
This also correlates with the increased degradation of polyubiquitinated proteins via autophagy 
observed (Fig. 56E). On the other hand, the autophagosome degradation after PARK2 overexpression 
maintains similar levels to the ones found in the absence of PARK2 in both SAD and healthy 
fibroblasts (Fig. 57E), highlighting that the improvement of autophagy flux is due to an increase in 
AV generation. 
Then, we assessed the possible effects of PARK2 overexpression in mitophagy process. PARK2 
transduction improved the targeting of PARK2 to the mitochondria after CCCP treatment in SAD 
fibroblasts (Fig. 58A). Additionally, the accumulation of either total or full length isoforms of PINK1 
in SAD samples was reduced after PARK2 overexpression to levels closer to the ones observed in 
healthy cells (Fig. 58B). Remarkably, PARK2 enhancement allowed a significant mitochondrial 
function improvement indicated by the ΔΨm recovery in SAD cells after a reversible CCCP challenge 
(Fig. 59A) which was negligible when they were uninfected (Fig. 41A). Finally, we could observe 
that the accumulation of TOMM20 label in SAD fibroblasts in basal conditions was restored by PARK2 
overexpression up to healthy levels (Fig. 59B-C). Moreover, in normal conditions or after CCCP 
treatment there was a clear recycling of mitochondria by lysosomal degradation in healthy samples 
that was not observed AD samples where there was an accumulation of mitochondria (Fig. 59D). But 
PARK2 overexpression dramatically improved mitochondrial recycling bypassing the impairment 
due to NH4Cl treatment (Fig. 59E). Overall, these data indicate that PARK2 overexpression 
compensates autophagy deficiency and restores mitophagy in SAD fibroblasts.  
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1. Peripheral vs neuronal models for the study of Alzheimer 
disease: Is there a peripheral failure in AD? 
Fibroblasts offer us an accessible cell source that can be obtained by a small skin biopsy from 
living patients. Furthermore, skin fibroblasts represent a model of primary human cells, involving the 
chronological and biological aging of patients according to their genetic and environmental 
predisposition factors. However, it is imperative to demonstrate that fibroblasts retain certain 
hallmarks of the disease, and, being the skin a tissue that is not affected in AD pathology, this is not a 
trivial issue. Several works have previously demonstrated that fibroblasts exhibit oxidized proteins 
accumulation and mitochondrial anomalies that can also be found in AD brain (Wang et al, 2014b). 
Moreover, accumulation of Aβ has been also demonstrated in these cells (Citron et al, 1994). It is well 
known that the loss of mitochondrial membrane potential with the uncoupler ionophore CCCP 
induces autophagic clearance of mammalian mitochondria (Narendra et al, 2008). In this thesis, we 
have demonstrated a deregulation in the proteins involved in the degradation of mitochondria under 
basal conditions, even though the activation of this process by the treatment with CCCP helped us to 
elucidate the mechanisms underlying the pathogenesis exacerbating the possible differences 
between AD and healthy cells. For biochemical studies, the ability to depolarize the mitochondria in a 
cell culture with CCCP has clear advantages (Narendra et al, 2008; Wang et al, 2011). It has been well 
demonstrated that endogenous PARK2 is able to be recruited to the mitochondria after 1h of CCCP 
treatment besides the induction of autophagy system (Narendra et al, 2008). The concentration and 
time of the treatment should be optimized depending of the cell type as well as the items to be 
addressed in each specific experiment. Thus, by immunostaining and biochemical methods is 
possible to analyze the subcellular location and interaction of the variety of proteins involve in 
mitophagy/autophagy process.  
Fibroblasts are a good tool for the study of the disease but it should be kept in mind that 
there are several important differences between peripheral cells and neurons. The differences in 
metabolic energy cost exhibited by these cells are substantial (Savage et al, 2007). Epithelial cells 
require a high metabolic rate for the frequent replacement to maintain function, turning over rapidly 
with many cell divisions to replace cells during the lifespan of the organism, but neurons are among 
the most metabolically active cells in the body and require constant maintenance due to the 
complexity of the molecular signaling that have. Fibroblasts reflect cumulative cell damage at the age 
of the patient, but the continuous replacement of these cells ameliorates the possible failure 
generated by the pathology. Although AD patients does not exhibit severe dermal changes, recently it 
has been published a work where patients with Rosacea, a chronic and potentially life-disruptive 
disorder primarily of the facial skin, have increased risk of dementia (Egeberg et al, 2016).  On the 
other hand, neurons are cells which cannot be replaced and particularly sensitive to oxidative 
damage and protein aggregation. Thus, neurons require all the machinery involve in detoxification to 
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maintain cell homeostasis. Therefore, the susceptibility of these cells to proteopathy and oxidative 
stress, as the main features of AD, are determinedly higher than fibroblasts. Additionally, it is 
fundamental to considerate that gene expression profile and their signaling could vary due to the 
differences in the expression of APP and Tau, the proteins involve in AD, in these cell models. 
Although APP is expressed in many tissues and fibroblasts revealed expression of this protein, APP is 
mainly concentrated in AD neurons (Israel et al, 2012). On the other hand, Tau is mostly expressed in 
neuronal and glial cells but it is also present in non-neural cells such as fibroblasts and lymphocytes 
(Ingelson et al, 1996; Rossi et al, 2008; Thurston et al, 1996). Contrary to these works, we could not 
report protein expression of Tau in our cell lines, therefore the difference between our fibroblast and 
neural models is the presence of Tau. We could observe that Tau plays an important role in the 
reclycling of mitochondria and its overexpression in fibroblasts reflects a similar failure obtained in 
FAD and SAD models. Moreover, we need to highlight that when Tau was present in each model, 
either by overexpression or in neurons derived from FAD1-iPSCs or in AD brain, the defect in 
mitophagy was increased reflected in a major accumulation of dysfunctional mitochondria. 
Therefore, we may conclude that Tau is a pivotal protein in mitophagy failure walking together with 
the deregulation pattern of several proteins involved in the process.  
Although fibroblasts and neurons exhibit basic differences in their biology we could 
recapitulate the mitophagy impairment in these two cells types in both FAD and SAD pathology.  
2. Opportunities and limitations of modelling Alzheimer 
disease with induced pluripotent stem cells 
The ability to generate patient-specific iPSCs through reprogramming of somatic cells and 
their subsequent differentiation into neuronal cell types, have boosted the investigation regarding 
the etiology of human neurodegenerative diseases, such as AD. While human iPSCs certainly provide 
great opportunities to repeatedly interrogate specific human brain cell types of individuals with 
familial and sporadic forms of the disease, the complex etiology and timescale over which AD 
develops in humans poses particular challenges to iPSC-based AD models. 
Literature indicates that most of the iPSC-AD studies are limited and larger cohorts of iPSCs 
from AD patients are being generated worldwide through various consortia, industry or iPSC banks. 
New York Stem Cell Foundation (NYSCF) research is focused on the modeling of different diseases and 
the development of cell therapies. This research center houses the platform “The NYSCF Global Stem 
Cell Array”, a new technology platform that, for the first time, creates and manipulates stem cell lines 
in a massively parallel process using automation. The NYSCF Alzheimer's disease team is developing 
a massive collection of iPSC lines on this platform from hundreds of Alzheimer patients’ skin samples. 
The Array fully automates the generation of standardized iPSC that can be used to study Alzheimer 
pathology. Moreover, it should be noted that work with this type of cells are expensive because the 
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general range for the iPSC line generation is $5,000 - $40,000 based on reprogramming method and 
specifications.  
We need to take into account the advantages and limitations that iPSC model system 
demonstrates. There is evidence that iPSCs, even from the same individual, can vary in terms of DNA 
mutation load (Gore et al, 2011), gene expression (Schondorf et al, 2014) and epigenetic signatures 
(Bock et al, 2011; Kim et al, 2010), often resulting in differences that may affect their propensity to 
differentiate into particular cell types (Nazor et al, 2012). Some of the variability appears to be driven 
by the method chosen to reprogram the somatic cells (non-integrating methods showing the least 
variability (Hartjes et al, 2014; Ma et al, 2014)), allelic variation (Lo et al, 2003), the age and type of 
cells used for reprogramming (Polo et al, 2010) and the culture time and method used to expand iPSC 
following establishment (Wutz, 2012). Moreover, the choice of the appropriate control for 
comparative studies of human samples is not a trivial one. Unaffected relative or parental control 
samples are preferable but these are not always available or come from family members of different 
age or gender and different genetic backgrounds. On the other hand, iPSCs are amenable to 
manipulation and genome editing while maintaining genome stability (Zhang et al, 2014). A variety 
of gene-editing techniques, such as zinc-finger nucleases  (Carroll, 2011), transcription activator-like 
effector nucleases (Woodruff et al, 2013), and the clustered regularly interspaced short palindromic 
repeat/Cas9 RNA-guided nuclease system (Paquet et al, 2016; Shalem et al, 2014) have been 
developed to facilitate investigation of specific genes and their functions. The advantage of isogenic 
lines is that only the disease-associated difference is studied, as the genetic background of the lines 
should be identical. Therefore, it seems advisable to both correct the mutation of interest in a 
patient-derived cell line, while in parallel introducing it in a control line. Therefore, genome editing 
will be an important strategy to minimize the effect of background variations in human iPS cell-
derived lines. Neural cells differentiated from iPSC lines with SAD backgrounds can display a number 
of AD-like phenotypes that can be characterized in vitro and represent an improvement of the 
knowledge of this AD phenotype. However, due to SAD may result from a combinatorial effect of 
genetic and non-genetic risk factors, the lack of a defined mutation makes difficult the generation of 
isogenic iPSC lines from SAD and control patients. The large scale analysis developed by human 
genome wide association studies (GWAS) have allowed the identification of AD markers that can 
predict disease risk and age onset. There is a recent study focused in iPSC derived from patients with 
SAD-associated variants in the SORL1 gene, which encodes a protein involved in endocytic 
trafficking, whose loss of expression has been reported in AD brains (Young et al, 2015). Therefore, 
the increased feasibility of genome editing in iPSCs will be relevant to elucidate the roles of SAD risk 
genetic variants in iPSC-derived neural models. Additionally, although it is difficult to be able to 
artificially recreate such a complex three-dimensional tissue as the human brain, iPSC technology is 
well suited to study paracrine interactions in the dish through the co-cultured of neurons from 
control or AD patients with astrocytes (Marchetto et al, 2008).  
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Glutamatergic and basal forebrain cholinergic neurons in the cerebral cortex and the 
hippocampus are thought to be cells that are affected at early stages and lost during AD pathogenesis 
(Braak & Braak, 1994). Thank to iPSC technology we have generated glutamatergic cortical forebrain 
neurons as most iPSC-AD modelling studies, that employed either embryoid body/neurosphere or 
small molecule-based neuronal differentiation protocols (Israel et al, 2012; Sproul et al, 2014). These   
iPSC-derived neurons from patient with the familiar etiology have reproduced the mitochondrial 
recycling failure observed in FAD1 fibroblasts. However, the development of protocols that allow the 
generation of specific and relevant cell types, such as basal forebrain cholinergic neurons are 
necessary. Additionally, protocols that mimic or accelerate the maturation and “ageing” processes 
are also fundamental to decipher the gene-regulatory networks involved in the disease. 
Finally, several studies reported the direct conversion or transdifferentiation of fibroblasts to 
neurons avoiding the pluripotent stage. It has been described that three neurodevelopmental factors, 
Brn2, Ascl1 and Myth1l, directly converted fibroblasts into neuronal cells, called induced neurons 
(iNs) (Vierbuchen et al, 2010). From this publication, it has appeared a collection of papers where the 
protocol has improved facilitating the conversion of fibroblasts into neuronal cells by using small 
molecules and also was reported for AD patients’ fibroblasts (Hu et al, 2015). Although the results 
have not been presented in this manuscript, we first tried to carry out the transdifferentiation in our 
cell lines due to this technology may seem easier. We tried the original protocol (Vierbuchen et al, 
2010) using the human analogs of the mentioned genes but, in our hands we could not reproduce 
successfully the results previously reported. Additionaly we tried the protocol described by Ladewig 
et al (2012) in which a combination of small molecules (SB-431542, Noggin and CHIR-99021) and 
two neuronal gene factors (Ascl1 and Ngn2) were used. In this case, we could obtain neuron-like cells 
that showed expression for mature neuron markers such as Tau, calbindin and NSE, but we could not 
achieve electric function in these cells. In our experience, transdifferentiation compared to iPSCs 
derived neurons is less efficient, poorly reproducible and the phenotype obtained is not always 
mature neurons with electric activity. 
3. Implication of PSEN1 Ala246Glu mutation in the 
mitochondrial recycling failure 
Presenilins are ubiquitously detected in many human tissues, including brain, heart, kidney 
and muscle (Lee et al, 1996). Moreover, it has described high levels of PSEN1 mRNA in both skin 
fibroblasts and brains from AD patients (Ikeda et al, 2000). Presenilin mutations are the main cause 
of autosomal-dominant FAD. Moreover, mutations in the PSEN1 gene, located on chromosome 14, 
occur most frequently in FAD (Cruts et al, 1998; Sherrington et al, 1995). Familial models bring the 
opportunity to characterize the pathology working with a specific mutation. We have focused our 
research in PSEN1 Ala246Glu mutation since it is a well-characterized FAD mutation that shows 
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typical phenotypes of AD with complete penetrance. PSEN1 A246E is reported to induce elevation of 
Aβ42 in human plasma, patient-derived fibroblasts, forced-expressed cells and showing strong 
toxicity in mice (Borchelt et al, 1996).  
We have analyzed the mitochondrial recycling process in fibroblasts from FAD patients 
carrying the mutation FAD1: PSEN1 Ala246Glu. The aim was to compare the results obtained in 
peripheral cells with a human neural model generated from iPSC harboring the same FAD1 mutation. 
We have demonstrated a deregulation of autophagy as a result of a reduction of degradation phase in 
both FAD1 fibroblasts and iPSC-derived neurons. This may be caused by an impaired fusion of the 
autophagic vesicles with lysosome or inhibition of lysosomal function. Consistently, we could observe 
that the acidification of lysosomes in FAD1 fibroblasts was diminished correlating with the lysosome 
acidification deficiency reported by Lee et al. (2010). In mentioned work, PSEN1 was demonstrated 
to act as chaperone protein that facilitates the N-glycosylation of V-ATPase subunit V0a1, which help 
V-ATPase traffic to lysosome and complete lysosome acidification. Furthermore, the accumulation of 
autophagic vesicles has been observed in dystrophic neurites around the amyloid plaques for 
decades. Likewise, the accumulation of p62 has been observed in neuronal and glial ubiquitin-
containing inclusions (Kuusisto et al, 2001) as well as in neurofibrillary tangles (Kuusisto et al, 2002) 
in AD brain. Therefore, all these results together demonstrate that PSEN1 mutations impair 
degradative phase of autophagy.  
The study of mitophagy after a mitochondrial insult indicates that this process is severely 
affected due to the mitochondrial accumulation exhibited in both fibroblasts and iPSC-derived 
neurons from FAD1 patients (See final model Fig. 60). These two cell types showed a correct FL-
PINK1 stabilization and PARK2 recruitment to mitochondria but, due to the degradation phase 
deficiency described before, there is an accumulation of damaged mitochondria which are not able to 
be recycled by mitophagy. This results correlate with the increased mitochondria in AVs, previously 
reported in pyramidal neurons from AD patients suggesting a mitophagy alteration (Moreira et al, 
2007b; Moreira et al, 2007c), as well as the PARK2/PINK1 accumulation observed. It is well known 
the accumulation of PINK1 and PARK2 in depolarized mitochondria to be degraded by autophagy 
(Narendra et al, 2010b; Tanaka, 2010). Moreover, PARK2 accumulation could be due to a proteasome 
degradation system saturation as a result of the autophagy impairment (Yamano et al, 2016). 
Additionally, we observed that FAD1 fibroblasts revealed lower levels of PINK1. It has been 
previously described that deficiency of PINK1 is a fundamental mechanism leading to accumulation 
of depolarized mitochondria (Bueno et al, 2015), therefore lower PINK1 expression in fibroblasts can 
contribute to a diminish targeting of dysfunctional mitochondria to be recycled by mitophagy. 
Conversely, in FAD1-iPSCs derived neurons the accumulation of mitochondria and PARK2 is 
substantially higher hence is logical to expect an additional accumulation of PINK1 stabilized in those 
mitochondria although its signaling was originally diminished.  
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On the other hand, it is relevant to remark a different role of presenilins in autophagy system. 
Presenilins mutations, including PSEN1 Ala246Glu, have been reported to cause abnormal 
intracellular calcium signaling promoting the release of Ca2+ from overloaded endoplasmic reticulum 
stores through inositol triphosphate receptor (IP3R) (Ito et al, 1994). It has described that PSEN1 
Ala246Glu enhances gating of the IP3R Ca2+ release channel by a gain of function effect, and is 
independent of the secretase function of PSEN1 (Cheung et al, 2010). Mutant PSEN1 enhances single 
channel activity of the IP3R by affecting modal gating kinetics, the major mechanism by which IP3 
and Ca2+ regulate the channel (Ionescu et al, 2007). This is important because autophagy appears to 
be directly dependent on the levels of endoplasmic reticulum’s Ca2+ and on the activity of IP3R. 
According to this, lysosomal fusion depends on both luminal acidification and local lysosomal Ca2+ 
release (Luzio et al, 2007; Saftig & Klumperman, 2009). It has described that PSEN1 deficient cells 
exhibited decreased Ca2+ storage in degradative organelles besides a significantly decreased 
lysosomal Ca2+ release demonstrating a cell type-independent function for PSEN1 in lysosomal Ca2+ 
homeostasis. The accumulation of AVs observed in FAD could be interpreted by PSEN1-related 
calcium abnormality promoting the consequent defect in lysosomal fusion and protein clearance 
(Coen et al, 2012). Moreover, neurons are more sensitive than fibroblasts to deregulation of Ca2+ 
levels, being an additional explanation for the preferential toxicity in this cell type.     
With respect to our FAD study, although we only could work with a couple of healthy/FAD1 
age- and sex-matched samples of fibroblast and iPS-derived neurons and further studies with more 
patients are needed, we have demonstrated for the first time a problem in mitochondrial recycling by 
mitophagy that correlates with previously described alterations in lysosomal function (Coen et al, 
2012; Lee et al, 2010; Neely et al, 2011). Moreover, we have recapitulated the mitochondrial 
recycling impairment showed in FAD1 fibroblasts in iPSC-derived neurons. In conclusion, our 
findings demonstrate that FAD1 iPSC-derived neurons are a valid model for the study of mitophagy 
impairment in AD.     
4. APP and Tau contribution in mitophagy.  
Extensive literature exists supporting a role of mitochondrial dysfunction and oxidative 
damage in the early AD pathogenesis (Moreira et al, 2006; Nunomura et al, 2001). There are strong 
indications that oxidative stress occurs prior to the onset of symptoms in AD and oxidative damage is 
found not only in the vulnerable regions of the brain affected in the disease (Casadesus et al, 2007; 
Nunomura et al, 2001) but also in peripheral cells (Moreira et al, 2007a). Mitochondrial function is 
regulated by autophagy and, for this porpose, segregation of damaged mitochondria depends on 
fission and fusion events that are altered in AD. It has been described an abnormal interaction of Aβ 
monomers and oligomers as well as hyperphosphorylated Tau with the mitochondrial fission protein 
DLP1 suggesting a possible cause of mitochondrial dynamics alteration and synaptic damage 
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(Manczak et al, 2011). In addition, the microtubule-directed traffic is a main player in the regulation 
of autophagy. Altered microtubule assembly impairs microtubule-dependent mitochondrial and 
autophagosomal transport toward lysosomes (Arduino et al, 2013). It is known that Aβ induces a 
reduction in motile mitochondria (Rui et al, 2006) and hyperphosphorylated Tau may block the 
transport of mitochondria and may disrupt the microtubule network trafficking leading to energy 
deprivation and oxidative stress (Stamer et al, 2002). Autophagy plays a fundamental role in 
neuronal function and is intensively involved in AD-related protein aggregation (Nixon et al, 2005) 
but little is known about the implication of APP and Tau in mitophagy dysfunction.  
We have analyzed the mitochondrial recycling process by the overexpression of APP and Tau 
in a human line of fibroblasts (See final model Fig. 60). We have demonstrated that overexpression 
of both APP and Tau proteins generates an activation of autophagy flux revealed by the enhanced 
activity of the autophagy degradation phase correlating with higher lysosomal activity. It might be 
reasonable to speculate that the boosting of autophagy flux may be a consequence of the proteotoxic 
stress generated by the overexpression of APP and Tau which are prone to aggregate 
(Bandyopadhyay et al, 2007; Spires et al, 2005). Further studies are needed regarding the increased 
autophagy degradation to discard a possible artefact of protein overexpression (Lamark & Johansen, 
2012).  
The study of mitochondrial recycling process revealed an increased mitochondrial content 
suggesting a compromised mitophagy in both APP and APP/Tau-expressing cells. Although we have 
demonstrated the same defect in both cases there are some differences. In the case of APP-expressing 
cells, we hypothesize that increased levels of PARK2 and PINK1 could be explain as an attempt to 
increase the mitochondrial recycling system. However, the diminished targeting of PARK2 and PINK1 
to mitochondria may reflect either an improvement of the recycling of mitochondria by the increased 
degradation phase of autophagy observed or an insufficient labelling of depolarized mitochondria to 
be degraded. In this regard, enhanced levels of Δ1-PINK1 may play an inhibitory effect over PARK2 
mitochondrial translocation contributing to defective label of damage mitochondria (Fedorowicz et 
al, 2014). Nevertheless, the study of mitochondrial ΔΨm recovery after CCCP insult indicates that a 
main part of mitochondria are able to be recycled properly although not as efficiently as control cells 
what may explain the slight accumulation of mitochondria, FL-PINK and PARK2. On the other hand, 
APP/Tau-expressing cells exhibited a dramatic accumulation of PINK1 in mitochondria after an 
insult but the recruitment of PARK2 to the mitochondria was decreased resulting in a defective 
labeling of damaged mitochondria demonstrating a deficient crosstalk between these two proteins. 
This resulted in a deficient mitochondrial ΔΨm recovery after CCCP challenge correlating with an 
major accumulation of mitochondria. According to our results, it has been recently described that 
Tau accumulation may induce mitophagy deficits by reducing level of PARK2 in the mitochondrial 
fraction (Hu et al, 2016). Moreover, increased levels of Δ1-PINK1 may also contribute to this deficit in 
mitochondrial targeting of PARK2 (Fedorowicz et al, 2014). This data together demonstrate a 
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worsening of mitophagy failure due to the presence of Tau. This can be related with two factors. 
First, the deterioration of mitochondrial function caused by the deregulation of mitochondrial 
respiratory chain complexes V and I (David et al, 2005; Schulz et al, 2012) as well as by the block of 
mitochondrial pores through VDAC1 interaction (Manczak & Reddy, 2012). And secondly, the 
mitochondrial dynamics alteration by Tau interaction with the fission protein DLP1 (Manczak et al, 
2011) accompanied with the interference of mitochondrial axonal transport by competition with 
their binding site to microtubules (Hagiwara et al, 1994). 
 In summary, we have demonstrate that the presence of Tau aggravates the defect showed by 
APP overexpression leading to a clear mitophagy failure showed by unachievable recovery of 
mitochondrial membrane potential after an insult that results in the accumulation of dysfunctional 
mitochondria labeled by PINK1.  
We have been able to demonstrate mitophagy impairment by overexpression of the two 
proteins mainly involved in AD. Although this is a good proof of concept and may help to understand 
the mechanisms involved in this pathology, this is only the simplest model and putative artifacts 
generated by supraphysiological expression levels need to be ruled out. Therefore it is crucial to 
validate these findings in more physiological models of the disease as well as in patients’ brain. With 
this aim, unmodified human skin fibroblasts and brain samples of sporadic AD patients have been 
used. Sporadic AD is not only the most prevalent form of this dementia but also is closely related to 
the accumulation of Aβ plaques derived from APP and neurofibrillary tangles generated by Tau. 
5. Mitophagy failure in sporadic AD.  
The majority of AD cases occur sporadically. SAD is a multifactorial neurodegenerative 
disorder arising from a number of different, but related biological alterations that contribute to the 
pathogenesis of the disease. In addition to the molecular, structural, and functional changes exhibited 
in AD patients, the individual differences in genetic background, environmental stimuli, lifestyle, and 
other risk factors potentially contribute to the pathology development (Stozicka et al, 2007).  Several 
genes involved in various metabolic pathways were presented as the genetic risk factors in SAD. The 
majority of these genes may influence the vulnerability of the central nerve system without direct 
impact on the primary causes of AD (Stozicka et al, 2007).  
Findings from recent AD genetic studies suggest that mitochondrial defects may play an 
important role in SAD progression, and that mitochondrial abnormalities and oxidative damage may 
play a significant role to initiate the disease (Reddy & Beal, 2005). The “mitochondrial cascade 
hypothesis” could explain many of the biochemical, genetic, and pathological features of sporadic AD 
(Swerdlow & Khan, 2004). Somatic mutations in mtDNA could cause energy failure, increased 
oxidative stress, and accumulation of Aβ, which in a vicious cycle reinforce the mtDNA damage and 
the oxidative stress (Mancuso et al, 2009). In addition, this hypothesis reconciles AD research with 
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brain aging research, provides insight into late-onset AD epidemiology and phenotype studies, and 
explains biochemical and physiologic changes that occur outside the AD brain. 
Taking into account the mitochondrial relevance in SAD, we have analyzed the mitochondrial 
recycling process in fibroblasts from SAD patients and have validated the mitophagy impairment in 
brains from AD patients (See final model Fig. 60). We have demonstrated that mitochondrial 
function was compromised due to the lack of membrane potential and ATP homeostasis recovery 
after the reversible treatment with CCCP suggesting an inefficient recycling of damaged mitochondria 
by autophagy in SAD fibroblasts. Accordingly, SAD cells showed a deficiency in autophagy induction 
and the accumulation of oxidized and ubiquitinated proteins. The absence of significant differences 
in BECN1 levels in SAD samples may be explained because autophagy can also occur independently 
of BECN1 (Chu et al, 2007; Zhu et al, 2007). Lysosomal anomalies have been also found in our SAD 
samples. We assume a reduction in the amount of lysosomes reflected by the diminished levels of 
LAMP1 and Cathepsin B proteins. However, we hypothesize that these lysosomes have a more acidic 
pH which correlates with enhanced Cathepsin B activity. In fact, it was previously described that 
lysosomal Cathepsin B exopeptidase activity is increased as the pH decreases (Polgar & Csoma, 
1987). Despite these anomalies, the lack of significant differences in the degradative phase of 
autophagy together with the active degradation of proteins mediated by autophagy such as p62 as 
well as similar rates of autophagosomes/lysosomes fusion, indicate that these lysosomes may be 
functional and suggest that the altered properties may be a consequence of autophagy failure. SAD 
fibroblasts demonstrated a failure in the induction of autophagy, meanwhile FAD1 fibroblasts 
showed a defective degradative phase of autophagy. These divergent phenotypes observed in SAD 
and FAD1 fibroblasts suggest different mechanisms for a common final failure in autophagy process. 
The study of mitophagy after a mitochondrial insult indicates that this process is severely 
affected in SAD fibroblasts. Upon mitochondrial depolarization, although there is a correct 
stabilization and auto-phosphorylation of PINK1, there is not a proper PARK2 activation. This may be 
due to the lower levels of PARK2 and its inhibition mediated the sequestration of cytosolic PARK2 by 
Δ1-PINK1. Accordingly, it has been described that  defects  in PARK2 recruitment correlates with 
declining ATP levels after the treatment with CCCP, such as we have observed for SAD samples, 
suggesting that CCCP-induced PARK2 mitochondrial translocation is ATP-sensitive (Lee et al, 2015). 
The deficient PARK2 recruitment to mitochondria in our SAD samples caused the accumulation of 
damaged mitochondria, reflected in the increase of FL- and phosphorylated-PINK1 and diminished 
phosphorylated-PARK2, emphasizing the deficiency in the crosstalk between PINK1 and PARK2. 
Furthermore, the defect in mitochondrial recycling may explain the accumulation of oxidized 
proteins observed. The situation observed in SAD fibroblasts was similar to what can be found in 
hippocampus from AD patients at early stages of the disease where we observed accumulation of 
both FL- and Δ1-PINK1 accompanied by abnormally increased mitochondrial content due to an 
impaired degradation rather than an increase in synthesis. This strongly suggests that mitophagy 
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failure may play an important role in the onset of the disease. At latest stages of the disease the 
increase of PARK2 may correlate with recently published results in which accumulation of insoluble 
PARK2 with intraneuronal Aβ and phospho-Tau was detected in autophagosomes in AD brains 
reflecting an autophagy failure (Lonskaya et al, 2013). Moreover, the upregulation of PARK2 in these 
patients’ brain has been suggested as a defense mechanism to counteract stress-induced damage in 
AD pathogenesis (Witte et al, 2009). Our findings demonstrate that SAD fibroblasts are a suitable 
model for the study of this dementia because they recapitulate similar alterations in mitophagy 
process to what it can be observed in patients’ brain. 
Finally, it is important to highlight that the autophagy and mitophagy failure uncovered in 
SAD samples must be substantially relevant since we have been able to characterize these 
deficiencies in a small collection of fibroblasts from different patients in which we have found similar 
features despite the multifactorial origin of SAD pathology.  
6. Relevance of Autophagy-Mitophagy system in AD  
Protein degradation is critical in cell quality control (Ciechanover, 2005). Disturbances in 
intracellular proteostasis trigger the accumulation of altered proteins and toxic aggregates as Aβ and 
hyperphosphorylated Tau widely recognized hallmarks of AD (Serrano-Pozo et al, 2011) . The major 
consequence of the accumulation of such pathogenic aggregates is the downregulation of proteolytic 
pathways triggering a feed-forward loop that at the end alter essential proteolytic networks. In 
addition, neurons are post-mitotic cells unable to dilute or remove abnormal protein aggregates via 
cell division and therefore are more sensitive to these toxic proteinaceous species compared to 
mitotic cells (Sitte et al, 2000a; Sitte et al, 2000b). 
Mounting evidence has implicated defective autophagy in the pathogenesis of AD. Autophagy 
is considerably involved in amyloid degradation (Yang et al, 2011). Autophagy and the Beclin1–
PIK3C3 complex regulate APP processing in AD (Jaeger et al, 2010). In addition, autophagic vesicles 
have been demonstrated to be an active compartment for Aߚ generation and their abnormal 
accumulation in affected neurons of the AD brain contributes to Aߚ deposition (Yu et al, 2004). 
Inhibition of Aߚ peptide aggregation rescues the autophagic deficits in a model of AD (Lai & 
McLaurin, 2012). On the other hand, the autophagy system plays a role in the clearance of Tau and 
the use of autophagy inhibitors delays Tau degradation favouring the formation of high molecular 
weight species of Tau including oligomers and insoluble aggregates (Hamano et al, 2008). Moreover, 
autophagy stimulation successfully reduces the number of Tau inclusions and improves nerve cell 
survival in a mouse model of human tauopathy (Schaeffer et al, 2012). Additionally, the lysosomal 
hydrolase cathepsin D was shown to degrade Tau proteins in cultured hippocampal slices (Bednarski 
& Lynch, 1996) demonstrating that Tau is susceptible of being degraded by autophagy.  
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Neurons represent a particularly interesting cell type for mitophagy because they combine 
high demand for mitochondria and high mitochondrial stress with extremely complex cellular 
architecture. Neurons face a unique challenge for mitochondrial turnover because a large fraction of 
the mitochondrial mass resides in distal axonal and dendritic processes, far away from the soma 
where most of the biogenesis is likely to occur and most of the lysosomes are thought to be located 
(Holtzman & Novikoff, 1965). Neuronal autophagy plays a critical role in the maintenance of 
homeostasis in distal axons and rapid elimination of dysfunctional mitochondria is probably critical 
for protection of neurons due to its impairment promotes the accumulation of oxidative damage and 
degeneration (Son et al, 2012). 
Taking into account the “mitochondrial cascade hypothesis” as a primary event in AD, a 
defective elimination of mitochondria could be taken place in the early pathology as we could 
observe (Fig. 53-54). Moreover, accumulation of damage mitochondria release high levels of Ca2+ 
and cytochrome c to the cytosol triggering apoptosis (Parsons & Green, 2010). Several articles have   
described mitophagy impairment in AD. It has been found an increase of autophagic vesicles 
containing mitochondria in pyramidal neurons from AD patients suggesting a mitophagy alteration 
(Moreira et al, 2007b; Moreira et al, 2007c). According to this, PARK2 has been shown to be reduced 
in the cortex of AD brains (Rosen et al, 2010) as we have described for SAD fibroblasts. Moreover, it 
has been shown that Tau accumulation impairs mitophagy reducing mitochondrial PARK2 (Hu et al, 
2016) as well as NH2-truncated human Tau induces deregulated mitophagy in neurons by aberrant 
recruitment of PARK2 (Corsetti et al, 2015). The present work adds new insights to previously 
suggested mitochondrial recycling deregulation in AD by deciphering the mechanisms involved in 
this failure in familial and sporadic forms of the disease as well as the contribution of APP and Tau to 
this pathology. Our results also support “mitochondrial cascade hypothesis” by proposing 
mitochondrial dysfunction as the onset of SAD.   
Along with the autophagy system, the proteasome mediates the degradation of short-lived, 
oxidatively damaged, modified and misfolded proteins both in the cytoplasm and the nucleus (Jung et 
al, 2009). Proteasome plays a crucial role in the processing of proteins involved in the onset of AD 
and its activity is heavily downregulated by protein aggregates in AD neurons (Cecarini et al, 2007; 
Keck et al, 2003). According to this, we also have demonstrated an increased in the ubiquitinated 
proteins suggesting dysfunctional proteasome degradation. Nevertheless, recent advances strongly 
suggest that autophagy/proteasome pathways are carefully orchestrated and some crosstalk 
mechanisms have been suggested (Kraft et al, 2010). In neurodegenerative conditions, when one 
proteolytic system is damaged and shows a reduced functionality, the enhanced activity of the other 
pathway may become a compensatory mechanism necessary to protect neuronal cells against the 
accumulation of toxic species (Ding et al, 2007; Pandey et al, 2007). Therefore, the fine collaboration 
between these two pathways is essential to protein quality control. In our hands, healthy fibroblasts 
exhibited a dual contribution of autophagy and proteasome systems for PARK2 degradation. Howev- 
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Figure 60. Summary of the mitophagy impairment studied in Alzheimer disease.  
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er, the contribution of autophagy for the degradation of polyubiquitinated proteins in healthy cells 
was only moderated and the majority was degraded by proteasome. Conversely, proteasome-
mediated degradation flux was enhanced in SAD samples while autophagy was completely blocked 
with respect to PARK2 degradation. This fact closely correlates with the behavior of 
polyubiquitinated protein levels in SAD fibroblasts where there was a null contribution of autophagy 
in degradation while proteasome role was enhanced, probably due to a compensatory mechanism to 
counteract autophagy impairment in SAD cells.  
Finally, although we studied the two distinct types of AD exhibiting different deregulation 
pattern of the mitochondrial recycling process, both SAD and FAD models converge on the same 
mitochondrial problem as is the mitophagy failure. 
7. PARK2: a potential therapeutic target in SAD 
Promoting the clearance of aggregated proteins via pharmacological induction of autophagy 
has proved to be a useful strategy for protecting against the toxic effects of these proteins in a range 
of cell and animal models (Berger et al, 2006; Ravikumar et al, 2002; Rose et al, 2010). In addition, 
mitochondrial biology represents a potentially useful, but relatively unexploited, area of therapeutic 
innovation. Emerging concepts of mitochondrial turnover and dynamics provides the opportunity to 
develop and evaluate mitochondrial based therapies. 
Taking into consideration our results in SAD fibroblasts where PARK2 levels were dimished 
we wanted to evaluate if PARK2 enhancement would be able to reverse the observed mitophagy 
deficiency in fibroblast. The overexpression of wild type PARK2 was able to improve autophagy 
shown in the recovery of autophagic vesicles under basal conditions up to the levels found in healthy 
samples. This improvement was reflected in the clearance of ubiquitinated proteins and the decrease 
of abnormal accumulated mitochondria. Additionally, PARK2 enhancement would exceed the 
inhibitory effect of Δ1 PINK1 and, upon CCCP treatment, PARK2 would be recruited by FL-PINK1 to 
damaged mitochondria leading them to be degraded by mitophagy. Consequently, the levels of PINK1 
were diminished and the ΔΨm was recovered by increasing of autophagy vesicle synthesis. We may 
thus assume that PARK2 overexpression restored autophagy and was able to compensate 
mitochondrial anomalies found in SAD fibroblasts. Previous work has demonstrated that the 
overexpression of PARK2 mediated the clearance of Aβ and phospho-Tau by enhancing autophagy 
and it was able to increase tricarboxylic acid cycle activity suggesting an improvement of 
mitochondrial function as well as a restored synaptic function in a triple transgenic AD mice model 
(Khandelwal et al, 2011; Lonskaya et al, 2013). Additionally, Parkin-induced autophagy facilitated 
clearance of vesicles containing debris and defective mitochondria counteracting oxidative stress and 
preventing mitochondrial dysfunction (Khandelwal et al, 2011). Taking all these evidences together, 
we may conclude that promoting autophagy by PARK2 overexpression restores mitochondrial 
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recycling and function, induces Aβ and phospho-Tau clearance and improves synaptic function. In 
this way, elimination of unsalvageable mitochondria prevents excessive intracellular oxidative stress 
and the pathologic accumulation of oxidized macromolecules that may propagate damage and 
interfere with redox signaling mechanisms. The most important point is that the therapeutic capacity 
of PARK2 enhancement that we have demonstrated in sporadic cases highlights not only the 
similarities with FAD but also with other neuropathies such as Parkinson’s disease, where the role of 
PARK2 has been widely demonstrated (Kitada et al, 1998). 
Other strategies for the induction of autophagy as a therapeutic target in AD have been tested 
in animal models for the disease. One of the best characterized autophagy inducer is rapamycin, 
which is already in clinical use for other indications (Cloughesy et al, 2008). In mammalian cells, 
rapamycin inhibits the kinase activity of mTOR by forming a complex with the immunophilin FK506-
binding protein of 12 kDa that binds to and inactivates mTOR, leading to the upregulation of 
autophagy (Caccamo et al, 2010; Spilman et al, 2010). On the other hand, Trehalose a natural 
disaccharide that can be found in animals, plants, and microorganisms induces autophagy via an 
mTOR independent pathway promoting the removal of aggregated proteins in a mouse model of 
human tauopathy (Schaeffer et al, 2012). In addition, Cystatin B deletion, an endogenous inhibitor of 
lysosomal cysteine proteases, can rescue autophagic-lysosomal pathology, reducing abnormal 
accumulations of Aβ peptide, ubiquitinated proteins and other autophagic substrates (Yang et al, 
2011). Latrepirdine, is an antihistamine drug that stimulates mTOR- and ATG5-dependent 
autophagy, leading to the reduction of intracellular levels of APP metabolites, including Aβ (Steele & 
Gandy, 2013). Moreover, scyllo-Inositol is an endogenous inositol stereoisomer known to inhibit 
aggregation and fibril formation of Aβ. It has described that inhibition of Aβ peptide aggregation 
rescues the autophagic deficits by the decrease in the size and number of accumulated autophagic 
vesicles in a mouse model of Alzheimer disease (Lai & McLaurin, 2012).  
To conclude, given the results obtained in this thesis, it must to be taken in consideration that 
autophagy defects in AD can occur at different points of the pathway. We have revealed an 
impairment of autophagosome induction as well as degradation in SAD and FAD, respectively. For 
that reason, every disease case should be carefully studied to determine the origin of autophagy 
failure to adjust the therapeutic approach to each patient problem. Therefore, Alzheimer disease is 
another complex disease whose efficient treatment will depend on future personalized medicine.
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1. Sporadic and familial AD fibroblasts as well as familial AD iPSC-derived neurons are suitable 
models for the study of mitophagy impairment in Alzheimer disease.  
2. APP overexpression promotes a mitochondrial recycling defect by impairing of PINK1 stabilization 
on mitochondria and the subsequent PARK2 recruitment leading to mitochondrial accumulation.  
3. The addition of Tau to the APP overexpression cellular model exacerbates the mitophagy failure 
promoting an increased accumulation of dysfunctional mitochondria labeled with PINK1.  
4. Patients-derived skin fibroblasts harboring PSEN1 Ala246Glu mutation demonstrate a defect in 
degradation phase of autophagy correlating with lysosomal anomalies, leading to dysfunctional 
mitochondria accumulation consistent with mitophagy impairment.  
5. Neurons derived from Alzheimer disease patients’ iPSC harboring PSEN1 Ala246Glu mutation 
demonstrate an exacerbation of mitophagy failure leading to increased mitochondrial accumulation 
together with augmented PINK1 and PARK2 levels.  
6. Fibroblasts derived from sporadic Alzheimer patients exhibit alterations in mitochondrial 
dynamics and function. This is accompanied by a deficiency in autophagy induction together with a 
defective labeling of mitochondria to be degraded by mitophagy due to decreased levels of PARK2, 
leading to the accumulation of dysfunctional mitochondria as well as oxidized and ubiquitinated 
proteins.  
7. Brains from Alzheimer disease patients show similar but aggravated mitophagy impairment 
exhibited by sporadic Alzheimer disease fibroblasts reflected in major accumulation of PINK1 and 
mitochondrial content especially at early stages of the disease.  
8. Neuronal models display an enhanced mitophagy failure compared to peripheral cells pattern in 
both sporadic and familial Alzheimer forms of the disease.   
9. PARK2 overexpression recover mitochondrial dynamics and functional defect besides autophagy 
and mitochondrial recycling failure revealed by sporadic Alzheimer disease fibroblasts, 
demonstrating that autophagy induction could be a relevant therapeutic strategy for Alzheimer 
disease.  
10. Mitochondrial recycling impairment is a common defect over all sporadic and familial Alzheimer 
disease models studied.  
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1. Los fibroblastos de pacientes tanto con la forma esporádica como familiar de la enfermedad de 
Alzheimer así como las neuronas derivadas de iPSC procedentes de pacientes de Alzheimer familiar 
son modelos adecuados para el estudio del defecto en mitofagia en dicha patología.  
2. La sobreexpresión de APP promueve un fallo en el reciclaje mitocondrial debido a un impedimento 
de la estabilización de PINK1 en la mitocondria y la consiguiente translocación de PARK2 que 
provoca la acumulación de mitocondrias.  
3. La adición de Tau al modelo celular de sobreexpresión de APP agrava el fallo en mitofagia 
promoviendo un aumento de la acumulación de mitocondrias no funcionales marcadas con PINK1. 
4. Los fibroblastos de la piel derivados de pacientes portadores de la mutación PSEN1 Ala246Glu 
presentan un defecto en la fase degradativa de la autofagia en correlación con anomalías lisosomales 
que conducen a la acumulación de mitocondrias no funcionales consecuente con el fallo en mitofagia. 
5. Las neuronas derivadas de iPSC de pacientes de Alzheimer portadores de la mutación PSEN1 
Ala246Glu muestran una exacerbación de la deficiencia en mitofagia lo que causa una mayor 
acumulación mitocondrial, junto con el aumento de los niveles de PINK1 y PARK2. 
6. Los fibroblastos derivados de pacientes con la forma esporádica de la enfermedad de Alzheimer 
manifiestan alteraciones en la dinámica y la función mitocondrial. Esto va acompañado de una 
inducción de autofagia deficiente junto con un marcaje defectuoso de las mitocondrias que van a ser 
degradadas por mitofagia como consecuencia de la disminución de los niveles de PARK2, lo que 
favorece la acumulación de mitocondrias  no funcionales, así como de proteínas oxidadas y 
ubiquitinadas. 
7. Los cerebros de pacientes de la enfermedad de Alzheimer muestran un deterioro en mitofagia 
similar, pero agravado, del presentado por los fibroblastos de la enfermedad de Alzheimer 
esporádica, lo que se refleja en una mayor acumulación de PINK1 y del contenido mitocondrial, 
especialmente en las etapas tempranas de la enfermedad. 
8. Los modelos neuronales muestran un fallo en autofagia exacerbado en comparación con el patrón 
mostrado por las células periféricas en ambas formas, esporádica y familiar, de la enfermedad de 
Alzheimer. 
9. La sobreexpresión de PARK2 recupera la dinámica mitocondrial y el defecto funcional además del 
fallo en autofagia y reciclaje mitocondrial mostrado por los fibroblastos con la forma esporádica de 
Alzheimer, lo que demuestra que la inducción de la autofagia podría ser una estrategia terapéutica 
relevante para la enfermedad de Alzheimer. 
10. El fallo en el reciclaje mitocondrial es un defecto común en todos los modelos, tanto esporádicos 
como familiares, de la enfermedad de Alzheimer estudiados.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
References 
 
 
 
 
 
 
References 
 
117 
 
Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, 
Tiscornia G, Edel M, Boue S, Izpisua Belmonte JC (2008) Efficient and rapid generation of induced 
pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276-1284 
 
Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, Ziolko SK, James JA, Snitz BE, 
Houck PR, Bi W, Cohen AD, Lopresti BJ, DeKosky ST, Halligan EM, Klunk WE (2008) Frequent 
amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol 65: 
1509-1517 
 
Alikhani N, Ankarcrona M, Glaser E (2009) Mitochondria and Alzheimer's disease: amyloid-beta 
peptide uptake and degradation by the presequence protease, hPreP. J Bioenerg Biomembr 41: 447-
451 
 
Alzheimer A, Stelzmann RA, Schnitzlein HN, Murtagh FR (1995) An English translation of 
Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin Anat 8: 429-431 
 
Ankarcrona M, Hultenby K (2002) Presenilin-1 is located in rat mitochondria. Biochem Biophys Res 
Commun 295: 766-770 
 
Arduino DM, Esteves AR, Cardoso SM (2013) Mitochondria drive autophagy pathology via 
microtubule disassembly: a new hypothesis for Parkinson disease. Autophagy 9: 112-114 
 
Area-Gomez E, Del Carmen Lara Castillo M, Tambini MD, Guardia-Laguarta C, de Groof AJ, Madra M, 
Ikenouchi J, Umeda M, Bird TD, Sturley SL, Schon EA (2012) Upregulated function of mitochondria-
associated ER membranes in Alzheimer disease. EMBO J 31: 4106-4123 
 
Auburger G, Klinkenberg M, Drost J, Marcus K, Morales-Gordo B, Kunz WS, Brandt U, Broccoli V, 
Reichmann H, Gispert S, Jendrach M (2012) Primary skin fibroblasts as a model of Parkinson's 
disease. Mol Neurobiol 46: 20-27 
 
Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and 
pathological conditions. Physiol Rev 84: 361-384 
 
Bandyopadhyay B, Li G, Yin H, Kuret J (2007) Tau aggregation and toxicity in a cell culture model of 
tauopathy. J Biol Chem 282: 16454-16464 
 
Bednarski E, Lynch G (1996) Cytosolic proteolysis of tau by cathepsin D in hippocampus following 
suppression of cathepsins B and L. J Neurochem 67: 1846-1855 
 
Behbahani H, Shabalina IG, Wiehager B, Concha H, Hultenby K, Petrovic N, Nedergaard J, Winblad B, 
Cowburn RF, Ankarcrona M (2006) Differential role of Presenilin-1 and -2 on mitochondrial 
membrane potential and oxygen consumption in mouse embryonic fibroblasts. J Neurosci Res 84: 
891-902 
 
Bekris LM, Yu CE, Bird TD, Tsuang DW (2010) Genetics of Alzheimer disease. J Geriatr Psychiatry 
Neurol 23: 213-227 
 
Belkacemi A, Ramassamy C (2012) Time sequence of oxidative stress in the brain from transgenic 
mouse models of Alzheimer's disease related to the amyloid-beta cascade. Free Radic Biol Med 52: 
593-600 
 
Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, 
Evert BO, O'Kane CJ, Rubinsztein DC (2006) Rapamycin alleviates toxicity of different aggregate-
prone proteins. Hum Mol Genet 15: 433-442 
 
Birgisdottir A, Lamark T, Johansen T (2013) The LIR motif - crucial for selective autophagy. J Cell Sci 
126: 3237-47 
 
 
 
References 
 
118 
 
Bissonnette CJ, Lyass L, Bhattacharyya BJ, Belmadani A, Miller RJ, Kessler JA (2011) The controlled 
generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. 
Stem Cells 29: 802-811 
 
Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, 
Oakley DH, Gnirke A, Eggan K, Meissner A (2011) Reference Maps of human ES and iPS cell 
variation enable high-throughput characterization of pluripotent cell lines. Cell 144: 439-452 
 
Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA (2010a) Oxidative stress in 
Alzheimer disease: a possibility for prevention. Neuropharmacology 59: 290-294 
 
Bonda DJ, Wang X, Perry G, Smith MA, Zhu X (2010b) Mitochondrial dynamics in Alzheimer's 
disease: opportunities for future treatment strategies. Drugs Aging 27: 181-192 
 
Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, 
Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price 
DL, Younkin SG, Sisodia SS (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate 
Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17: 1005-1013 
 
Bossy B, Petrilli A, Klinglmayr E, Chen J, Lutz-Meindl U, Knott AB, Masliah E, Schwarzenbacher R, 
Bossy-Wetzel E (2010) S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific 
to Alzheimer's disease. J Alzheimers Dis 20 Suppl 2: S513-526 
 
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta 
Neuropathol 82: 239-259 
 
Braak H, Braak E (1994) Morphological criteria for the recognition of Alzheimer's disease and the 
distribution pattern of cortical changes related to this disorder. Neurobiol Aging 15: 355-356; 
discussion 379-380 
 
Bueno M, Lai YC, Romero Y, Brands J, St Croix CM, Kamga C, Corey C, Herazo-Maya JD, Sembrat J, Lee 
JS, Duncan SR, Rojas M, Shiva S, Chu CT, Mora AL (2015) PINK1 deficiency impairs mitochondrial 
homeostasis and promotes lung fibrosis. J Clin Invest 125: 521-538 
 
Butterfield DA (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: 
implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36: 
1307-1313 
 
Caccamo A, Majumder S, Richardson A, Strong R, Oddo S (2010) Molecular interplay between 
mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J 
Biol Chem 285: 13107-13120 
 
Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH (2011) Impaired mitochondrial biogenesis, 
defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic 
degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 20: 4515-4529 
 
Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, 
Martin C, Charbonnier F, Raux G, Camuzat A, Penet C, Mesnage V, Martinez M, Clerget-Darpoux F, 
Brice A, Frebourg T (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic 
heterogeneity, and mutation spectrum. Am J Hum Genet 65: 664-670 
 
Carlsson CM (2010) Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease. J Alzheimers 
Dis 20: 711-722 
 
Carroll D (2011) Genome engineering with zinc-finger nucleases. Genetics 188: 773-782 
 
Casadesus G, Smith MA, Basu S, Hua J, Capobianco DE, Siedlak SL, Zhu X, Perry G (2007) Increased 
isoprostane and prostaglandin are prominent in neurons in Alzheimer disease. Mol Neurodegener 
2:  
 
References 
 
119 
 
Cataldo AM, Barnett JL, Pieroni C, Nixon RA (1997) Increased neuronal endocytosis and protease 
delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a 
mechanism of increased beta-amyloidogenesis. J Neurosci 17: 6142-6151 
 
Cataldo AM, Nixon RA (1990) Enzymatically active lysosomal proteases are associated with 
amyloid deposits in Alzheimer brain. Proc Natl Acad Sci U S A 87: 3861-3865 
 
Cecarini V, Ding Q, Keller JN (2007) Oxidative inactivation of the proteasome in Alzheimer's disease. 
Free Radic Res 41: 673-680 
 
Cecchi C, Fiorillo C, Sorbi S, Latorraca S, Nacmias B, Bagnoli S, Nassi P, Liguri G (2002) Oxidative 
stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free 
Radic Biol Med 33: 1372-1379 
 
Ciechanover A (2005) Intracellular protein degradation: from a vague idea, through the lysosome 
and the ubiquitin-proteasome system, and onto human diseases and drug targeting (Nobel lecture). 
Angew Chem Int Ed Engl 44: 5944-5967 
 
Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, Craessaerts K, Metzger K, Frezza C, Annaert W, 
D'Adamio L, Derks C, Dejaegere T, Pellegrini L, D'Hooge R, Scorrano L, De Strooper B (2006) 
Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-
dependent cristae remodeling. Cell 126: 163-175 
 
Citron M, Diehl TS, Gordon G, Biere AL, Seubert P, Selkoe DJ (1996) Evidence that the 42- and 40-
amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein 
by different protease activities. Proc Natl Acad Sci U S A 93: 13170-13175 
 
Citron M, Vigo-Pelfrey C, Teplow DB, Miller C, Schenk D, Johnston J, Winblad B, Venizelos N, Lannfelt 
L, Selkoe DJ (1994) Excessive production of amyloid beta-protein by peripheral cells of 
symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease 
mutation. Proc Natl Acad Sci U S A 91: 11993-11997 
 
Clayton KB, Podlesniy P, Figueiro-Silva J, Lopez-Domenech G, Benitez L, Enguita M, Abad MA, 
Soriano E, Trullas R (2012) NP1 regulates neuronal activity-dependent accumulation of BAX in 
mitochondria and mitochondrial dynamics. J Neurosci 32: 1453-1466 
 
Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, Zhu S, Hsueh T, Chen Y, Wang W, 
Youngkin D, Liau L, Martin N, Becker D, Bergsneider M, Lai A, Green R, Oglesby T, Koleto M, Trent J, 
Horvath S, Mischel PS, Mellinghoff IK, Sawyers CL (2008) Antitumor activity of rapamycin in a 
Phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med 5: e8 
 
Coen K, Flannagan RS, Baron S, Carraro-Lacroix LR, Wang D, Vermeire W, Michiels C, Munck S, Baert 
V, Sugita S, Wuytack F, Hiesinger PR, Grinstein S, Annaert W (2012) Lysosomal calcium homeostasis 
defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells. J Cell 
Biol 198: 23-35 
 
Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, 
Bryden L, Halperin RF, Marlowe L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J, 
Papassotiropoulos A, Reiman EM, Hardy J, Stephan DA (2007) A high-density whole-genome 
association study reveals that APOE is the major susceptibility gene for sporadic late-onset 
Alzheimer's disease. J Clin Psychiatry 68: 613-618 
 
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, 
Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's 
disease in late onset families. Science 261: 921-923 
 
Corsetti V, Florenzano F, Atlante A, Bobba A, Ciotti MT, Natale F, Della Valle F, Borreca A, Manca A, 
Meli G, Ferraina C, Feligioni M, D'Aguanno S, Bussani R, Ammassari-Teule M, Nicolin V, Calissano P, 
Amadoro G (2015) NH2-truncated human tau induces deregulated mitophagy in neurons by 
 
References 
 
120 
 
aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease. Hum Mol Genet 
24: 3058-3081 
 
Coulson EJ, Paliga K, Beyreuther K, Masters CL (2000) What the evolution of the amyloid protein 
precursor supergene family tells us about its function. Neurochem Int 36: 175-184 
 
Cruts M, Theuns J, Van Broeckhoven C (2012) Locus-specific mutation databases for 
neurodegenerative brain diseases. Hum Mutat 33: 1340-1344 
 
Cruts M, van Duijn CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, Sherrington R, 
Hutton M, Hardy J, St George-Hyslop PH, Hofman A, Van Broeckhoven C (1998) Estimation of the 
genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile 
Alzheimer disease. Hum Mol Genet 7: 43-51 
 
Cuervo AM (2004) Autophagy: in sickness and in health. Trends Cell Biol 14: 70-77 
 
Cuervo AM (2010) Chaperone-mediated autophagy: selectivity pays off. Trends Endocrinol Metab 
21: 142-150 
 
Cummings JL (2004) Alzheimer's disease. N Engl J Med 351: 56-67 
 
Cunningham M, Cho JH, Leung A, Savvidis G, Ahn S, Moon M, Lee PK, Han JJ, Azimi N, Kim KS, 
Bolshakov VY, Chung S (2014) hPSC-derived maturing GABAergic interneurons ameliorate seizures 
and abnormal behavior in epileptic mice. Cell Stem Cell 15: 559-573 
 
Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L (2009) Highly 
efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat 
Biotechnol 27: 275-280 
 
Chandrasekaran K, Hatanpaa K, Brady DR, Rapoport SI (1996) Evidence for physiological down-
regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp Neurol 142: 80-88 
 
Chandrasekaran K, Hatanpaa K, Rapoport SI, Brady DR (1997) Decreased expression of nuclear and 
mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in 
Alzheimer disease. Brain Res Mol Brain Res 44: 99-104 
 
Cheung KH, Mei L, Mak DO, Hayashi I, Iwatsubo T, Kang DE, Foskett JK (2010) Gain-of-function 
enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin 
mutants in human cells and mouse neurons. Sci Signal 3: ra22 
 
Chiong M, Cartes-Saavedra B, Norambuena-Soto I, Mondaca-Ruff D, Morales PE, Garcia-Miguel M, 
Mellado R (2014) Mitochondrial metabolism and the control of vascular smooth muscle cell 
proliferation. Front Cell Dev Biol 2: 72 
 
Chu CT, Zhu J, Dagda R (2007) Beclin 1-independent pathway of damage-induced mitophagy and 
autophagic stress: implications for neurodegeneration and cell death. Autophagy 3: 663-666 
 
da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A, Safe S, Abou-Sleiman PM, Wood NW, 
Takahashi H, Goldberg MS, Shen J, Checler F (2009) Transcriptional repression of p53 by parkin 
and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. 
Nat Cell Biol 11: 1370-1375 
 
Dagda RK, Cherra SJ, 3rd, Kulich SM, Tandon A, Park D, Chu CT (2009) Loss of PINK1 function 
promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem 284: 
13843-13855 
 
David DC, Hauptmann S, Scherping I, Schuessel K, Keil U, Rizzu P, Ravid R, Drose S, Brandt U, Muller 
WE, Eckert A, Gotz J (2005) Proteomic and functional analyses reveal a mitochondrial dysfunction 
in P301L tau transgenic mice. J Biol Chem 280: 23802-23814 
 
References 
 
121 
 
 
De Strooper B, Iwatsubo T, Wolfe MS (2012) Presenilins and gamma-secretase: structure, function, 
and role in Alzheimer Disease. Cold Spring Harb Perspect Med 2: a006304 
 
de Toledo Ferraz Alves TC, Ferreira LK, Wajngarten M, Busatto GF (2010) Cardiac disorders as risk 
factors for Alzheimer's disease. J Alzheimers Dis 20: 749-763 
 
Detmer SA, Chan DC (2007) Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol 
Cell Biol 8: 870-879 
 
Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK (2006) Accumulation of 
amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease 
brain is associated with mitochondrial dysfunction. J Neurosci 26: 9057-9068 
 
Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK (1992) 
Identification of normal and pathological aging in prospectively studied nondemented elderly 
humans. Neurobiol Aging 13: 179-189 
 
Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel 
R, Goland R, Wichterle H, Henderson CE, Eggan K (2008) Induced pluripotent stem cells generated 
from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221 
 
Ding WX, Ni HM, Gao W, Yoshimori T, Stolz DB, Ron D, Yin XM (2007) Linking of autophagy to 
ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and 
cell viability. Am J Pathol 171: 513-524 
 
Ding WX, Yin XM (2012) Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol Chem 
393: 547-564 
 
Drechsel DN, Hyman AA, Cobb MH, Kirschner MW (1992) Modulation of the dynamic instability of 
tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 3: 1141-1154 
 
Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, 
Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD (2008) Cyclophilin D deficiency attenuates 
mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's 
disease. Nat Med 14: 1097-1105 
 
Duan L, Bhattacharyya BJ, Belmadani A, Pan L, Miller RJ, Kessler JA (2014) Stem cell derived basal 
forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death. 
Mol Neurodegener 9: 3 
 
DuBoff B, Gotz J, Feany MB (2012) Tau promotes neurodegeneration via DRP1 mislocalization in 
vivo. Neuron 75: 618-632 
 
Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, 
Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, Tanzi RE, Cappai R, Barnham KJ, 
Ciccotosto GD, Rogers JT, Bush AI (2010) Iron-export ferroxidase activity of beta-amyloid precursor 
protein is inhibited by zinc in Alzheimer's disease. Cell 142: 857-867 
 
Dupont N, Temime-Smaali N, Lafont F (2010) How ubiquitination and autophagy participate in the 
regulation of the cell response to bacterial infection. Biol Cell 102: 621-634 
 
Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E (1998) Overexpression of 
tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic 
reticulum: implications for Alzheimer's disease. J Cell Biol 143: 777-794 
 
Egeberg A, Hansen PR, Gislason GH, Thyssen JP (2016) Patients with rosacea have increased risk of 
dementia. Ann Neurol 
 
 
References 
 
122 
 
Eiraku M, Watanabe K, Matsuo-Takasaki M, Kawada M, Yonemura S, Matsumura M, Wataya T, 
Nishiyama A, Muguruma K, Sasai Y (2008) Self-organized formation of polarized cortical tissues 
from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 3: 519-532 
 
Esclatine A, Chaumorcel M, Codogno P (2009) Macroautophagy signaling and regulation. Curr Top 
Microbiol Immunol 335: 33-70 
 
Escobar-Khondiker M, Hollerhage M, Muriel MP, Champy P, Bach A, Depienne C, Respondek G, 
Yamada ES, Lannuzel A, Yagi T, Hirsch EC, Oertel WH, Jacob R, Michel PP, Ruberg M, Hoglinger GU 
(2007) Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured 
neurons. J Neurosci 27: 7827-7837 
 
Fedorowicz MA, de Vries-Schneider RL, Rub C, Becker D, Huang Y, Zhou C, Alessi Wolken DM, Voos 
W, Liu Y, Przedborski S (2014) Cytosolic cleaved PINK1 represses Parkin translocation to 
mitochondria and mitophagy. EMBO Rep 15: 86-93 
 
Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor AR, McLean CA, Cao D, 
Rigopoulos A, Cartwright GA, O'Keefe G, Gong S, Adlard PA, Barnham KJ, Rowe CC, Masters CL, Kudo 
Y, Cappai R, Yanai K, Villemagne VL (2011) 18F-THK523: a novel in vivo tau imaging ligand for 
Alzheimer's disease. Brain 134: 1089-1100 
 
Fotuhi M, Hachinski V, Whitehouse PJ (2009) Changing perspectives regarding late-life dementia. 
Nat Rev Neurol 5: 649-658 
 
Fraldi A, Annunziata F, Lombardi A, Kaiser HJ, Medina DL, Spampanato C, Fedele AO, Polishchuk R, 
Sorrentino NC, Simons K, Ballabio A (2010) Lysosomal fusion and SNARE function are impaired by 
cholesterol accumulation in lysosomal storage disorders. EMBO J 29: 3607-3620 
 
Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL, Youle RJ (2001) 
The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 1: 
515-525 
 
Frazier AE, Kiu C, Stojanovski D, Hoogenraad NJ, Ryan MT (2006) Mitochondrial morphology and 
distribution in mammalian cells. Biol Chem 387: 1551-1558 
 
Fridman AL, Tainsky MA (2008) Critical pathways in cellular senescence and immortalization 
revealed by gene expression profiling. Oncogene 27: 5975-5987 
 
Funderburk SF, Marcellino BK, Yue Z (2010) Cell "self-eating" (autophagy) mechanism in 
Alzheimer's disease. Mt Sinai J Med 77: 59-68 
 
Gallego MJ, Porayette P, Kaltcheva MM, Bowen RL, Vadakkadath Meethal S, Atwood CS (2010) The 
pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic 
stem cell proliferation and differentiation into neuroectodermal rosettes. Stem Cell Res Ther 1: 28 
 
Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G (2012) Mitochondrial control of cellular life, stress, 
and death. Circ Res 111: 1198-1207 
 
Ganley IG, Wong PM, Gammoh N, Jiang X (2011) Distinct autophagosomal-lysosomal fusion 
mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell 42: 731-743 
 
Garcia-Escudero V, Garcia-Gomez A, Gargini R, Martin-Bermejo MJ, Langa E, de Yebenes JG, Delicado 
A, Avila J, Moreno-Flores MT, Lim F (2010) Prevention of senescence progression in reversibly 
immortalized human ensheathing glia permits their survival after deimmortalization. Mol Ther 18: 
394-403 
 
Garcia-Escudero V, Martin-Maestro P, Perry G, Avila J (2013) Deconstructing mitochondrial 
dysfunction in Alzheimer disease. Oxid Med Cell Longev 2013: 162152 
 
 
References 
 
123 
 
Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W (2010) 
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 
119-131 
 
Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P (1988) Reduced activities of 
thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's 
disease. Arch Neurol 45: 836-840 
 
Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the 
cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as 
the microtubule-associated protein tau. Proc Natl Acad Sci U S A 85: 4051-4055 
 
Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, 
Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, 
Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS, Zhang K 
(2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471: 63-67 
 
Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, McBride HM, Park DS, Fon EA 
(2012) Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin 
recruitment. EMBO Rep 13: 378-385 
 
Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM (1986a) Microtubule-
associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261: 6084-
6089 
 
Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986b) Abnormal 
phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal 
pathology. Proc Natl Acad Sci U S A 83: 4913-4917 
 
Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ (1993) beta-Amyloid peptide and a 3-
kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268: 3021-3024 
 
Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo 
EH, Schenk D, Teplow DB, et al. (1992) Amyloid beta-peptide is produced by cultured cells during 
normal metabolism. Nature 359: 322-325 
 
Haass C, Selkoe DJ (1993) Cellular processing of beta-amyloid precursor protein and the genesis of 
amyloid beta-peptide. Cell 75: 1039-1042 
 
Hagiwara H, Yorifuji H, Sato-Yoshitake R, Hirokawa N (1994) Competition between motor 
molecules (kinesin and cytoplasmic dynein) and fibrous microtubule-associated proteins in binding 
to microtubules. J Biol Chem 269: 3581-3589 
 
Hamano T, Gendron TF, Causevic E, Yen SH, Lin WL, Isidoro C, Deture M, Ko LW (2008) Autophagic-
lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau 
expression. Eur J Neurosci 27: 1119-1130 
 
Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, 
Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R (2008) Direct reprogramming of 
terminally differentiated mature B lymphocytes to pluripotency. Cell 133: 250-264 
 
Hanna JH, Saha K, Jaenisch R (2010) Pluripotency and cellular reprogramming: facts, hypotheses, 
unresolved issues. Cell 143: 508-525 
 
Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, Ito A, Winblad B, 
Cowburn RF, Thyberg J, Ankarcrona M (2004) Nicastrin, presenilin, APH-1, and PEN-2 form active 
gamma-secretase complexes in mitochondria. J Biol Chem 279: 51654-51660 
 
 
References 
 
124 
 
Hartjes KA, Li X, Martinez-Fernandez A, Roemmich AJ, Larsen BT, Terzic A, Nelson TJ (2014) 
Selection via pluripotency-related transcriptional screen minimizes the influence of somatic origin 
on iPSC differentiation propensity. Stem Cells 32: 2350-2359 
 
Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE 
(2009) Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in 
AD transgenic mice. Neurobiol Aging 30: 1574-1586 
 
He C, Klionsky DJ (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev 
Genet 43: 67-93 
 
Hirano A, Dembitzer HM, Kurland LT, Zimmerman HM (1968) The fine structure of some 
intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" 
structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J 
Neuropathol Exp Neurol 27: 167-182 
 
Hokama M, Oka S, Leon J, Ninomiya T, Honda H, Sasaki K, Iwaki T, Ohara T, Sasaki T, LaFerla FM, 
Kiyohara Y, Nakabeppu Y (2014) Altered expression of diabetes-related genes in Alzheimer's 
disease brains: the Hisayama study. Cereb Cortex 24: 2476-2488 
 
Holtzman E, Novikoff AB (1965) Lysomes in the rat sciatic nerve following crush. J Cell Biol 27: 651-
669 
 
Hu W, Qiu B, Guan W, Wang Q, Wang M, Li W, Gao L, Shen L, Huang Y, Xie G, Zhao H, Jin Y, Tang B, Yu 
Y, Zhao J, Pei G (2015) Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts 
into Neuronal Cells by Small Molecules. Cell Stem Cell 17: 204-212 
 
Hu Y, Li XC, Wang ZH, Luo Y, Zhang X, Liu XP, Feng Q, Wang Q, Yue Z, Chen Z, Ye K, Wang JZ, Liu GP 
(2016) Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and 
reducing mitochondrial parkin. Oncotarget 
 
Huang C, Andres AM, Ratliff EP, Hernandez G, Lee P, Gottlieb RA (2011) Preconditioning involves 
selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 6: e20975 
 
Iijima-Ando K, Sekiya M, Maruko-Otake A, Ohtake Y, Suzuki E, Lu B, Iijima KM (2012) Loss of axonal 
mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau 
phosphorylation via PAR-1. PLoS Genet 8: e1002918 
 
Ikeda K, Urakami K, Arai H, Wada K, Wakutani Y, Ji Y, Adachi Y, Okada A, Kowa H, Sasaki H, Ohno K, 
Ohtsuka Y, Ishikawa Y, Nakashima K (2000) The expression of presenilin 1 mRNA in skin 
fibroblasts and brains from sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 11: 245-250 
 
Imai Y (2012) Mitochondrial Regulation by PINK1-Parkin Signaling. ISRN Cell Biology 2012: 15 
 
Ingelson M, Vanmechelen E, Lannfelt L (1996) Microtubule-associated protein tau in human 
fibroblasts with the Swedish Alzheimer mutation. Neurosci Lett 220: 9-12 
 
Ionescu L, White C, Cheung KH, Shuai J, Parker I, Pearson JE, Foskett JK, Mak DO (2007) Mode 
switching is the major mechanism of ligand regulation of InsP3 receptor calcium release channels. J 
Gen Physiol 130: 631-645 
 
Ishihara N, Fujita Y, Oka T, Mihara K (2006) Regulation of mitochondrial morphology through 
proteolytic cleavage of OPA1. EMBO J 25: 2966-2977 
 
Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, Hefferan MP, Van Gorp S, Nazor KL, 
Boscolo FS, Carson CT, Laurent LC, Marsala M, Gage FH, Remes AM, Koo EH, Goldstein LS (2012) 
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 
482: 216-220 
 
 
References 
 
125 
 
Itakura E, Kishi-Itakura C, Mizushima N (2012) The hairpin-type tail-anchored SNARE syntaxin 17 
targets to autophagosomes for fusion with endosomes/lysosomes. Cell 151: 1256-1269 
 
Ito E, Oka K, Etcheberrigaray R, Nelson TJ, McPhie DL, Tofel-Grehl B, Gibson GE, Alkon DL (1994) 
Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc Natl 
Acad Sci U S A 91: 534-538 
 
Jaeger PA, Pickford F, Sun CH, Lucin KM, Masliah E, Wyss-Coray T (2010) Regulation of amyloid 
precursor protein processing by the Beclin 1 complex. PLoS One 5: e11102 
 
Jahreiss L, Menzies FM, Rubinsztein DC (2008) The itinerary of autophagosomes: from peripheral 
formation to kiss-and-run fusion with lysosomes. Traffic 9: 574-587 
 
Jicha GA, Rockwood JM, Berenfeld B, Hutton M, Davies P (1999) Altered conformation of 
recombinant frontotemporal dementia-17 mutant tau proteins. Neurosci Lett 260: 153-156 
 
Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ (2010) Mitochondrial membrane 
potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 191: 933-942 
 
Jung SS, Nalbantoglu J, Cashman NR (1996) Alzheimer's beta-amyloid precursor protein is 
expressed on the surface of immediately ex vivo brain cells: a flow cytometric study. J Neurosci Res 
46: 336-348 
 
Jung T, Catalgol B, Grune T (2009) The proteasomal system. Mol Aspects Med 30: 191-296 
 
Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, Masutani H, Yodoi J, Urano 
Y, Nagano T, Ichijo H (2005) Amyloid beta induces neuronal cell death through ROS-mediated ASK1 
activation. Cell Death Differ 12: 19-24 
 
Kagan BL, Azimov R, Azimova R (2004) Amyloid peptide channels. J Membr Biol 202: 1-10 
 
Kahler DJ, Ahmad FS, Ritz A, Hua H, Moroziewicz DN, Sproul AA, Dusenberry CR, Shang L, Paull D, 
Zimmer M, Weiss KA, Egli D, Noggle SA (2013) Improved methods for reprogramming human 
dermal fibroblasts using fluorescence activated cell sorting. PLoS One 8: e59867 
 
Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, Banerjee S, Youle RJ (2014) PINK1 
phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol 205: 143-153 
 
Kang DE, Roh SE, Woo JA, Liu T, Bu JH, Jung AR, Lim Y (2011) The Interface between Cytoskeletal 
Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders. Exp 
Neurobiol 20: 67-80 
 
Katsuragi Y, Ichimura Y, Komatsu M (2015) p62/SQSTM1 functions as a signaling hub and an 
autophagy adaptor. FEBS J: 10.1111/febs.13540 
 
Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A (1988) Clinical, 
pathological, and neurochemical changes in dementia: a subgroup with preserved mental status 
and numerous neocortical plaques. Ann Neurol 23: 138-144 
 
Kawas CH, Corrada MM (2006) Alzheimer's and dementia in the oldest-old: a century of challenges. 
Curr Alzheimer Res 3: 411-419 
 
Keck S, Nitsch R, Grune T, Ullrich O (2003) Proteasome inhibition by paired helical filament-tau in 
brains of patients with Alzheimer's disease. J Neurochem 85: 115-122 
 
Khandelwal PJ, Herman AM, Hoe HS, Rebeck GW, Moussa CE (2011) Parkin mediates beclin-
dependent autophagic clearance of defective mitochondria and ubiquitinated Abeta in AD models. 
Hum Mol Genet 20: 2091-2102 
 
 
References 
 
126 
 
Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, 
Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, 
Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ 
(2010) Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290 
 
Kim TS, Misumi S, Jung CG, Masuda T, Isobe Y, Furuyama F, Nishino H, Hida H (2008a) Increase in 
dopaminergic neurons from mouse embryonic stem cell-derived neural progenitor/stem cells is 
mediated by hypoxia inducible factor-1alpha. J Neurosci Res 86: 2353-2362 
 
Kim Y, Park J, Kim S, Song S, Kwon SK, Lee SH, Kitada T, Kim JM, Chung J (2008b) PINK1 controls 
mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 
377: 975-980 
 
Kimura S, Noda T, Yoshimori T (2007) Dissection of the autophagosome maturation process by a 
novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3: 452-460 
 
Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T (2006) Phosphate-binding tag, a new tool to 
visualize phosphorylated proteins. Mol Cell Proteomics 5: 749-757 
 
Kirkin V, McEwan DG, Novak I, Dikic I (2009) A role for ubiquitin in selective autophagy. Mol Cell 
34: 259-269 
 
Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, 
Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 
Nature 392: 605-608 
 
Klionsky DJ (2005) The molecular machinery of autophagy: unanswered questions. J Cell Sci 118: 7-
18 
 
Klionsky DJ (2007) Autophagy: from phenomenology to molecular understanding in less than a 
decade. Nat Rev Mol Cell Biol 8: 931-937 
 
Klionsky DJ, et al (2016) Guidelines for the use and interpretation of assays for monitoring 
autophagy (3rd edition). Autophagy 12: 1-222 
 
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang 
GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, 
Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer's disease with 
Pittsburgh Compound-B. Ann Neurol 55: 306-319 
 
Ko LW, Sheu KF, Thaler HT, Markesbery WR, Blass JP (2001) Selective loss of KGDHC-enriched 
neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective 
vulnerability? J Mol Neurosci 17: 361-369 
 
Koch P, Tamboli IY, Mertens J, Wunderlich P, Ladewig J, Stuber K, Esselmann H, Wiltfang J, Brustle 
O, Walter J (2012) Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit 
partial loss of gamma-secretase activity in endogenous amyloid-beta generation. Am J Pathol 180: 
2404-2416 
 
Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, 
Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, Warabi E, Yoshida H, Ishii T, 
Kobayashi A, Yamamoto M, Yue Z, Uchiyama Y, Kominami E, Tanaka K (2007) Homeostatic levels of 
p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149-
1163 
 
Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, 
Takahashi K, Asaka I, Aoi T, Watanabe A, Watanabe K, Kadoya C, Nakano R, Watanabe D, Maruyama 
K, Hori O, Hibino S, Choshi T, Nakahata T, Hioki H, Kaneko T, Naitoh M, Yoshikawa K, Yamawaki S, 
Suzuki S, Hata R, Ueno S, Seki T, Kobayashi K, Toda T, Murakami K, Irie K, Klein WL, Mori H, Asada 
 
References 
 
127 
 
T, Takahashi R, Iwata N, Yamanaka S, Inoue H (2013) Modeling Alzheimer's disease with iPSCs 
reveals stress phenotypes associated with intracellular Abeta and differential drug responsiveness. 
Cell Stem Cell 12: 487-496 
 
Korolchuk VI, Mansilla A, Menzies FM, Rubinsztein DC (2009) Autophagy inhibition compromises 
degradation of ubiquitin-proteasome pathway substrates. Mol Cell 33: 517-527 
 
Kosik KS, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein tau (tau) is a major 
antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A 83: 
4044-4048 
 
Koyano F, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsuchiya H, Yoshihara H, 
Hirokawa T, Endo T, Fon EA, Trempe JF, Saeki Y, Tanaka K, Matsuda N (2014) Ubiquitin is 
phosphorylated by PINK1 to activate parkin. Nature 510: 162-166 
 
Kraft C, Peter M, Hofmann K (2010) Selective autophagy: ubiquitin-mediated recognition and 
beyond. Nat Cell Biol 12: 836-841 
 
Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, 
Larson EB (2002) Dementia and Alzheimer disease incidence: a prospective cohort study. Arch 
Neurol 59: 1737-1746 
 
Kuo SH, Tang G, Ma K, Babij R, Cortes E, Vonsattel JP, Faust PL, Sulzer D, Louis ED (2012) 
Macroautophagy abnormality in essential tremor. PLoS One 7: e53040 
 
Kuusisto E, Salminen A, Alafuzoff I (2001) Ubiquitin-binding protein p62 is present in neuronal and 
glial inclusions in human tauopathies and synucleinopathies. Neuroreport 12: 2085-2090 
 
Kuusisto E, Salminen A, Alafuzoff I (2002) Early accumulation of p62 in neurofibrillary tangles in 
Alzheimer's disease: possible role in tangle formation. Neuropathol Appl Neurobiol 28: 228-237 
 
Ladewig J, Mertens J, Kesavan J, Doerr J, Poppe D, Glaue F, Herms S, Wernet P, Kogler G, Muller FJ, 
Koch P, Brustle O (2012) Small molecules enable highly efficient neuronal conversion of human 
fibroblasts. Nat Methods 9: 575-578 
 
Lai AY, McLaurin J (2012) Inhibition of amyloid-beta peptide aggregation rescues the autophagic 
deficits in the TgCRND8 mouse model of Alzheimer disease. Biochim Biophys Acta 1822: 1629-1637 
 
Lamark T, Johansen T (2012) Aggrephagy: selective disposal of protein aggregates by 
macroautophagy. Int J Cell Biol 2012: 736905 
 
Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, Homfray T, Penninger JM, 
Jackson AP, Knoblich JA (2013) Cerebral organoids model human brain development and 
microcephaly. Nature 501: 373-379 
 
Lazarou M, Jin SM, Kane LA, Youle RJ (2012) Role of PINK1 binding to the TOM complex and 
alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev Cell 22: 
320-333 
 
Lee H, Shamy GA, Elkabetz Y, Schofield CM, Harrsion NL, Panagiotakos G, Socci ND, Tabar V, Studer 
L (2007) Directed differentiation and transplantation of human embryonic stem cell-derived 
motoneurons. Stem Cells 25: 1931-1939 
 
Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-
Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon RA 
(2010) Lysosomal proteolysis and autophagy require presenilin 1 and are 
disrupted by Alzheimer-related PS1 mutations. Cell 141: 1146-1158 
 
 
References 
 
128 
 
Lee MK, Slunt HH, Martin LJ, Thinakaran G, Kim G, Gandy SE, Seeger M, Koo E, Price DL, Sisodia SS 
(1996) Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci 16: 
7513-7525 
 
Lee S, Zhang C, Liu X (2015) Role of glucose metabolism and ATP in maintaining PINK1 levels 
during Parkin-mediated mitochondrial damage responses. J Biol Chem 290: 904-917 
 
Lee VM, Balin BJ, Otvos L, Jr., Trojanowski JQ (1991) A68: a major subunit of paired helical 
filaments and derivatized forms of normal Tau. Science 251: 675-678 
 
Lemasters JJ (2005) Selective mitochondrial autophagy, or mitophagy, as a targeted defense against 
oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 8: 3-5 
 
Li WW, Li J, Bao JK (2012) Microautophagy: lesser-known self-eating. Cell Mol Life Sci 69: 1125-
1136 
 
Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, Abujarour R, Lin X, Hahm HS, Hao E, Hayek A, Ding S 
(2009) A chemical platform for improved induction of human iPSCs. Nat Methods 6: 805-808 
 
Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, 
Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR (2011) 
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 
471: 68-73 
 
Liu Q, Spusta SC, Mi R, Lassiter RN, Stark MR, Hoke A, Rao MS, Zeng X (2012) Human neural crest 
stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, 
and differentiation into functional schwann cells. Stem Cells Transl Med 1: 266-278 
 
Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP (2003) Allelic variation in gene 
expression is common in the human genome. Genome Res 13: 1855-1862 
 
Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ (2009) 
Generation of induced pluripotent stem cells from human blood. Blood 113: 5476-5479 
 
Lonskaya I, Shekoyan AR, Hebron ML, Desforges N, Algarzae NK, Moussa CE (2013) Diminished 
parkin solubility and co-localization with intraneuronal amyloid-beta are associated with 
autophagic defects in Alzheimer's disease. J Alzheimers Dis 33: 231-247 
 
LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI (1995) Functional implications 
for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci U S 
A 92: 10369-10373 
 
Loson OC, Song Z, Chen H, Chan DC (2013) Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment 
in mitochondrial fission. Mol Biol Cell 24: 659-667 
 
Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, 
Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, 
Yan SS, Wu H (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. 
Science 304: 448-452 
 
Luzio JP, Bright NA, Pryor PR (2007) The role of calcium and other ions in sorting and delivery in 
the late endocytic pathway. Biochem Soc Trans 35: 1088-1091 
 
Llorens-Martin M, Lopez-Domenech G, Soriano E, Avila J (2011) GSK3beta is involved in the relief of 
mitochondria pausing in a Tau-dependent manner. PLoS One 6: e27686 
 
Ma H, Morey R, O'Neil RC, He Y, Daughtry B, Schultz MD, Hariharan M, Nery JR, Castanon R, Sabatini 
K, Thiagarajan RD, Tachibana M, Kang E, Tippner-Hedges R, Ahmed R, Gutierrez NM, Van Dyken C, 
Polat A, Sugawara A, Sparman M, Gokhale S, Amato P, Wolf DP, Ecker JR, Laurent LC, Mitalipov S 
 
References 
 
129 
 
(2014) Abnormalities in human pluripotent cells due to reprogramming mechanisms. Nature 511: 
177-183 
 
Mahairaki V, Ryu J, Peters A, Chang Q, Li T, Park TS, Burridge PW, Talbot CC, Jr., Asnaghi L, Martin 
LJ, Zambidis ET, Koliatsos VE (2014) Induced pluripotent stem cells from familial Alzheimer's 
disease patients differentiate into mature neurons with amyloidogenic properties. Stem Cells Dev 
23: 2996-3010 
 
Mancuso M, Calsolaro V, Orsucci D, Carlesi C, Choub A, Piazza S, Siciliano G (2009) Mitochondria, 
cognitive impairment, and Alzheimer's disease. Int J Alzheimers Dis 2009 
 
Manczak M, Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal 
interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with 
Alzheimer's disease: implications for neuronal damage. Hum Mol Genet 20: 2495-2509 
 
Manczak M, Reddy PH (2012) Abnormal interaction of VDAC1 with amyloid beta and 
phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease. Hum Mol Genet 21: 
5131-5146 
 
Manley S, Williams JA, Ding WX (2013) Role of p62/SQSTM1 in liver physiology and pathogenesis. 
Exp Biol Med (Maywood) 238: 525-538 
 
Marchetto MC, Muotri AR, Mu Y, Smith AM, Cezar GG, Gage FH (2008) Non-cell-autonomous effect of 
human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell 
Stem Cell 3: 649-657 
 
Martinez-Vicente M, Talloczy Z, Wong E, Tang G, Koga H, Kaushik S, de Vries R, Arias E, Harris S, 
Sulzer D, Cuervo AM (2010) Cargo recognition failure is responsible for inefficient autophagy in 
Huntington's disease. Nat Neurosci 13: 567-576 
 
Massey A, Kiffin R, Cuervo AM (2004) Pathophysiology of chaperone-mediated autophagy. Int J 
Biochem Cell Biol 36: 2420-2434 
 
Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin 
of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the 
amyloid of plaque cores and blood vessels. EMBO J 4: 2757-2763 
 
Matteoni R, Kreis TE (1987) Translocation and clustering of endosomes and lysosomes depends on 
microtubules. J Cell Biol 105: 1253-1265 
 
Meissner C, Lorenz H, Weihofen A, Selkoe DJ, Lemberg MK (2011) The mitochondrial 
intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J Neurochem 
117: 856-867 
 
Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D, Schilling B, Mavros C, Masters CL, 
Volitakis I, Li QX, Laughton K, Hubbard A, Cherny RA, Gibson B, Bush AI (2007) Mitochondrial 
oxidative stress causes hyperphosphorylation of tau. PLoS One 2: e536 
 
Mertens J, Stuber K, Wunderlich P, Ladewig J, Kesavan JC, Vandenberghe R, Vandenbulcke M, van 
Damme P, Walter J, Brustle O, Koch P (2013) APP processing in human pluripotent stem cell-
derived neurons is resistant to NSAID-based gamma-secretase modulation. Stem Cell Reports 1: 
491-498 
 
Mishra P, Chan DC (2014) Mitochondrial dynamics and inheritance during cell division, 
development and disease. Nat Rev Mol Cell Biol 15: 634-646 
 
Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH (2010) Mitofusin 2 is necessary for 
transport of axonal mitochondria and interacts with the Miro/Milton complex. J Neurosci 30: 4232-
4240 
 
References 
 
130 
 
 
Moore S, Evans LD, Andersson T, Portelius E, Smith J, Dias TB, Saurat N, McGlade A, Kirwan P, 
Blennow K, Hardy J, Zetterberg H, Livesey FJ (2015) APP metabolism regulates tau proteostasis in 
human cerebral cortex neurons. Cell Rep 11: 689-696 
 
Moreira PI, Cardoso SM, Santos MS, Oliveira CR (2006) The key role of mitochondria in Alzheimer's 
disease. J Alzheimers Dis 9: 101-110 
 
Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G (2010) Mitochondrial dysfunction is a trigger of 
Alzheimer's disease pathophysiology. Biochim Biophys Acta 1802: 2-10 
 
Moreira PI, Harris PL, Zhu X, Santos MS, Oliveira CR, Smith MA, Perry G (2007a) Lipoic acid and N-
acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient 
fibroblasts. J Alzheimers Dis 12: 195-206 
 
Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, 
Smith MA, Zhu X, Perry G (2007b) Autophagocytosis of mitochondria is prominent in Alzheimer 
disease. J Neuropathol Exp Neurol 66: 525-532 
 
Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, 
Smith MA, Zhu X, Perry G (2007c) Increased autophagic degradation of mitochondria in Alzheimer 
disease. Autophagy 3: 614-615 
 
Morris JC, Storandt M, McKeel DW, Jr., Rubin EH, Price JL, Grant EA, Berg L (1996) Cerebral amyloid 
deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild 
Alzheimer's disease. Neurology 46: 707-719 
 
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to 
proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63 
 
Muratore CR, Rice HC, Srikanth P, Callahan DG, Shin T, Benjamin LN, Walsh DM, Selkoe DJ, Young-
Pearse TL (2014) The familial Alzheimer's disease APPV717I mutation alters APP processing and 
Tau expression in iPSC-derived neurons. Hum Mol Genet 23: 3523-3536 
 
Naderi J, Lopez C, Pandey S (2006) Chronically increased oxidative stress in fibroblasts from 
Alzheimer's disease patients causes early senescence and renders resistance to apoptosis by 
oxidative stress. Mech Ageing Dev 127: 25-35 
 
Narendra D, Kane LA, Hauser DN, Fearnley IM, Youle RJ (2010a) p62/SQSTM1 is required for 
Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. 
Autophagy 6: 1090-1106 
 
Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired 
mitochondria and promotes their autophagy. J Cell Biol 183: 795-803 
 
Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ (2010b) PINK1 is 
selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298 
 
Nazor KL, Altun G, Lynch C, Tran H, Harness JV, Slavin I, Garitaonandia I, Muller FJ, Wang YC, 
Boscolo FS, Fakunle E, Dumevska B, Lee S, Park HS, Olee T, D'Lima DD, Semechkin R, Parast MM, 
Galat V, Laslett AL, Schmidt U, Keirstead HS, Loring JF, Laurent LC (2012) Recurrent variations in 
DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 
10: 620-634 
 
Neely KM, Green KN, LaFerla FM (2011) Presenilin is necessary for efficient proteolysis through the 
autophagy-lysosome system in a gamma-secretase-independent manner. J Neurosci 31: 2781-2791 
 
Neve RL, McPhie DL, Chen Y (2000) Alzheimer's disease: a dysfunction of the amyloid precursor 
protein(1). Brain Res 886: 54-66 
 
References 
 
131 
 
 
Ni HM, Williams JA, Ding WX (2015) Mitochondrial dynamics and mitochondrial quality control. 
Redox Biol 4: 6-13 
 
Nicholas CR, Chen J, Tang Y, Southwell DG, Chalmers N, Vogt D, Arnold CM, Chen YJ, Stanley EG, 
Elefanty AG, Sasai Y, Alvarez-Buylla A, Rubenstein JL, Kriegstein AR (2013) Functional maturation 
of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural 
development. Cell Stem Cell 12: 573-586 
 
Nikfarjam L, Farzaneh P (2012) Prevention and detection of Mycoplasma contamination in cell 
culture. Cell J 13: 203-212 
 
Nixon RA (2005) Endosome function and dysfunction in Alzheimer's disease and other 
neurodegenerative diseases. Neurobiol Aging 26: 373-382 
 
Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM (2005) Extensive 
involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J 
Neuropathol Exp Neurol 64: 113-122 
 
Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, 
Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Oxidative damage is the earliest 
event in Alzheimer disease. J Neuropathol Exp Neurol 60: 759-767 
 
Okatsu K, Oka T, Iguchi M, Imamura K, Kosako H, Tani N, Kimura M, Go E, Koyano F, Funayama M, 
Shiba-Fukushima K, Sato S, Shimizu H, Fukunaga Y, Taniguchi H, Komatsu M, Hattori N, Mihara K, 
Tanaka K, Matsuda N (2012) PINK1 autophosphorylation upon membrane potential dissipation is 
essential for Parkin recruitment to damaged mitochondria. Nat Commun 3: 1016 
 
Okatsu K, Saisho K, Shimanuki M, Nakada K, Shitara H, Sou YS, Kimura M, Sato S, Hattori N, Komatsu 
M, Tanaka K, Matsuda N (2010) p62/SQSTM1 cooperates with Parkin for perinuclear clustering of 
depolarized mitochondria. Genes Cells 15: 887-900 
 
Orvedahl A, Sumpter R, Jr., Xiao G, Ng A, Zou Z, Tang Y, Narimatsu M, Gilpin C, Sun Q, Roth M, Forst 
CV, Wrana JL, Zhang YE, Luby-Phelps K, Xavier RJ, Xie Y, Levine B (2011) Image-based genome-wide 
siRNA screen identifies selective autophagy factors. Nature 480: 113-117 
 
Ozawa K, Komatsubara AT, Nishimura Y, Sawada T, Kawafune H, Tsumoto H, Tsuji Y, Zhao J, Kyotani 
Y, Tanaka T, Takahashi R, Yoshizumi M (2013) S-nitrosylation regulates mitochondrial quality 
control via activation of parkin. Sci Rep 3: 2202 
 
Pagani L, Eckert A (2011) Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis 2011: 
925050 
 
Palmer CS, Osellame LD, Laine D, Koutsopoulos OS, Frazier AE, Ryan MT (2011) MiD49 and MiD51, 
new components of the mitochondrial fission machinery. EMBO Rep 12: 565-573 
 
Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, Schwartz SL, DiProspero NA, 
Knight MA, Schuldiner O, Padmanabhan R, Hild M, Berry DL, Garza D, Hubbert CC, Yao TP, 
Baehrecke EH, Taylor JP (2007) HDAC6 rescues neurodegeneration and provides an essential link 
between autophagy and the UPS. Nature 447: 859-863 
 
Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T 
(2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein 
aggregates by autophagy. J Biol Chem 282: 24131-24145 
 
Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M 
(2016) Efficient introduction of specific homozygous and heterozygous mutations using 
CRISPR/Cas9. Nature 533: 125-129 
 
 
References 
 
132 
 
Parsons MJ, Green DR (2010) Mitochondria in cell death. Essays Biochem 47: 99-114 
 
Perry EK, Perry RH, Tomlinson BE, Blessed G, Gibson PH (1980) Coenzyme A-acetylating enzymes 
in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase. Neurosci 
Lett 18: 105-110 
 
Piaceri I, Nacmias B, Sorbi S (2013) Genetics of familial and sporadic Alzheimer's disease. Front 
Biosci (Elite Ed) 5: 167-177 
 
Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, 
Rockenstein E, Levine B, Wyss-Coray T (2008) The autophagy-related protein beclin 1 shows 
reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J 
Clin Invest 118: 2190-2199 
 
Polgar L, Csoma C (1987) Dissociation of ionizing groups in the binding cleft inversely controls the 
endo- and exopeptidase activities of cathepsin B. J Biol Chem 262: 14448-14453 
 
Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, 
Natesan S, Wagers AJ, Melnick A, Evans T, Hochedlinger K (2010) Cell type of origin influences the 
molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 28: 
848-855 
 
Porayette P, Gallego MJ, Kaltcheva MM, Bowen RL, Vadakkadath Meethal S, Atwood CS (2009) 
Differential processing of amyloid-beta precursor protein directs human embryonic stem cell 
proliferation and differentiation into neuronal precursor cells. J Biol Chem 284: 23806-23817 
 
Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (2006) Synapse formation and 
function is modulated by the amyloid precursor protein. J Neurosci 26: 7212-7221 
 
Raber J, Huang Y, Ashford JW (2004) ApoE genotype accounts for the vast majority of AD risk and 
AD pathology. Neurobiol Aging 25: 641-650 
 
Rademakers R, Cruts M, Van Broeckhoven C (2003) Genetics of early-onset Alzheimer dementia. 
ScientificWorldJournal 3: 497-519 
 
Ravikumar B, Duden R, Rubinsztein DC (2002) Aggregate-prone proteins with polyglutamine and 
polyalanine expansions are degraded by autophagy. Hum Mol Genet 11: 1107-1117 
 
Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? 
Brain Res Brain Res Rev 49: 618-632 
 
Rose C, Menzies FM, Renna M, Acevedo-Arozena A, Corrochano S, Sadiq O, Brown SD, Rubinsztein 
DC (2010) Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of 
Huntington's disease. Hum Mol Genet 19: 2144-2153 
 
Rosen KM, Moussa CE, Lee HK, Kumar P, Kitada T, Qin G, Fu Q, Querfurth HW (2010) Parkin 
reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function. J 
Neurosci Res 88: 167-178 
 
Rossi G, Dalpra L, Crosti F, Lissoni S, Sciacca FL, Catania M, Di Fede G, Mangieri M, Giaccone G, Croci 
D, Tagliavini F (2008) A new function of microtubule-associated protein tau: involvement in 
chromosome stability. Cell Cycle 7: 1788-1794 
 
Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, 
Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, 
Masters CL, Villemagne VL (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 
68: 1718-1725 
 
 
References 
 
133 
 
Rui Y, Tiwari P, Xie Z, Zheng JQ (2006) Acute impairment of mitochondrial trafficking by beta-
amyloid peptides in hippocampal neurons. J Neurosci 26: 10480-10487 
 
Saftig P, Klumperman J (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking 
meets function. Nat Rev Mol Cell Biol 10: 623-635 
 
Sandoe J, Eggan K (2013) Opportunities and challenges of pluripotent stem cell neurodegenerative 
disease models. Nat Neurosci 16: 780-789 
 
Santa-Maria I, Hernandez F, Martin CP, Avila J, Moreno FJ (2004) Quinones facilitate the self-
assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry 
43: 2888-2897 
 
Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, Zhu X (2010) A synergistic 
dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J 
Alzheimers Dis 20 Suppl 2: S401-412 
 
Savage VM, Allen AP, Brown JH, Gillooly JF, Herman AB, Woodruff WH, West GB (2007) Scaling of 
number, size, and metabolic rate of cells with body size in mammals. Proc Natl Acad Sci U S A 104: 
4718-4723 
 
Saxton WM, Hollenbeck PJ (2012) The axonal transport of mitochondria. J Cell Sci 125: 2095-2104 
 
Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT, Goedert M (2012) Stimulation of autophagy 
reduces neurodegeneration in a mouse model of human tauopathy. Brain 135: 2169-2177 
 
Scheper W, Nijholt DA, Hoozemans JJ (2011) The unfolded protein response and proteostasis in 
Alzheimer disease: preferential activation of autophagy by endoplasmic reticulum stress. 
Autophagy 7: 910-911 
 
Schmidt ML, Zhukareva V, Newell KL, Lee VM, Trojanowski JQ (2001) Tau isoform profile and 
phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol 
101: 518-524 
 
Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Gotz J, Eckert A (2012) Insights into 
mitochondrial dysfunction: aging, amyloid-beta, and tau-A deleterious trio. Antioxid Redox Signal 
16: 1456-1466 
 
Schon EA, Area-Gomez E (2010) Is Alzheimer's disease a disorder of mitochondria-associated 
membranes? J Alzheimers Dis 20 Suppl 2: S281-292 
 
Schondorf DC, Aureli M, McAllister FE, Hindley CJ, Mayer F, Schmid B, Sardi SP, Valsecchi M, 
Hoffmann S, Schwarz LK, Hedrich U, Berg D, Shihabuddin LS, Hu J, Pruszak J, Gygi SP, Sonnino S, 
Gasser T, Deleidi M (2014) iPSC-derived neurons from GBA1-associated Parkinson's disease 
patients show autophagic defects and impaired calcium homeostasis. Nat Commun 5: 4028 
 
Schuessel K, Frey C, Jourdan C, Keil U, Weber CC, Muller-Spahn F, Muller WE, Eckert A (2006) Aging 
sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. Free Radic 
Biol Med 40: 850-862 
 
Schulz KL, Eckert A, Rhein V, Mai S, Haase W, Reichert AS, Jendrach M, Muller WE, Leuner K (2012) 
A new link to mitochondrial impairment in tauopathies. Mol Neurobiol 46: 205-216 
 
Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741-766 
 
Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298: 789-791 
 
Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in 
Alzheimer disease. Cold Spring Harb Perspect Med 1: a006189 
 
References 
 
134 
 
 
Sha D, Chin LS, Li L (2010) Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 
activates parkin E3 ligase function and NF-kappaB signaling. Hum Mol Genet 19: 352-363 
 
Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, 
Doench JG, Zhang F (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 
343: 84-87 
 
Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, 
Tsuda T, Mar L, Foncin JF, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, 
Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HA, Haines JL, Perkicak-Vance MA, 
Tanzi RE, Roses AD, Fraser PE, Rommens JM, St George-Hyslop PH (1995) Cloning of a gene bearing 
missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760 
 
Sheu KF, Cooper AJ, Koike K, Koike M, Lindsay JG, Blass JP (1994) Abnormality of the alpha-
ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann Neurol 
35: 312-318 
 
Shin RW, Iwaki T, Kitamoto T, Tateishi J (1991) Hydrated autoclave pretreatment enhances tau 
immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest 64: 
693-702 
 
Sitte N, Merker K, Von Zglinicki T, Davies KJ, Grune T (2000a) Protein oxidation and degradation 
during cellular senescence of human BJ fibroblasts: part II--aging of nondividing cells. FASEB J 14: 
2503-2510 
 
Sitte N, Merker K, Von Zglinicki T, Grune T, Davies KJ (2000b) Protein oxidation and degradation 
during cellular senescence of human BJ fibroblasts: part I--effects of proliferative senescence. 
FASEB J 14: 2495-2502 
 
Smirnova E, Griparic L, Shurland DL, van der Bliek AM (2001) Dynamin-related protein Drp1 is 
required for mitochondrial division in mammalian cells. Mol Biol Cell 12: 2245-2256 
 
Soba P, Eggert S, Wagner K, Zentgraf H, Siehl K, Kreger S, Lower A, Langer A, Merdes G, Paro R, 
Masters CL, Muller U, Kins S, Beyreuther K (2005) Homo- and heterodimerization of APP family 
members promotes intercellular adhesion. EMBO J 24: 3624-3634 
 
Son JH, Shim JH, Kim KH, Ha JY, Han JY (2012) Neuronal autophagy and neurodegenerative 
diseases. Exp Mol Med 44: 89-98 
 
Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, 
Galvan V (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces 
amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One 5: e9979 
 
Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai BJ, Hyman BT 
(2005) Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated 
by gene transfer and intravital multiphoton microscopy. J Neurosci 25: 7278-7287 
 
Sprenger A, Kuttner V, Biniossek ML, Gretzmeier C, Boerries M, Mack C, Has C, Bruckner-Tuderman 
L, Dengjel J (2010) Comparative quantitation of proteome alterations induced by aging or 
immortalization in primary human fibroblasts and keratinocytes for clinical applications. Mol 
Biosyst 6: 1579-1582 
 
Sproul AA, Jacob S, Pre D, Kim SH, Nestor MW, Navarro-Sobrino M, Santa-Maria I, Zimmer M, Aubry 
S, Steele JW, Kahler DJ, Dranovsky A, Arancio O, Crary JF, Gandy S, Noggle SA (2014) 
Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural 
progenitors. PLoS One 9: e84547 
 
 
References 
 
135 
 
Stadtfeld M, Brennand K, Hochedlinger K (2008) Reprogramming of pancreatic beta cells into 
induced pluripotent stem cells. Curr Biol 18: 890-894 
 
Stadtfeld M, Hochedlinger K (2010) Induced pluripotency: history, mechanisms, and applications. 
Genes Dev 24: 2239-2263 
 
Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM (2002) Tau blocks traffic of organelles, 
neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156: 1051-
1063 
 
Steele JW, Gandy S (2013) Latrepirdine (Dimebon(R)), a potential Alzheimer therapeutic, regulates 
autophagy and neuropathology in an Alzheimer mouse model. Autophagy 9: 617-618 
 
Stozicka Z, Zilka N, Novak M (2007) Risk and protective factors for sporadic Alzheimer's disease. 
Acta Virol 51: 205-222 
 
Strazielle C, Jazi R, Verdier Y, Qian S, Lalonde R (2009) Regional brain metabolism with cytochrome 
c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: 
correlations with behavior and oxidative stress. Neurochem Int 55: 806-814 
 
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD 
(1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 
allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90: 1977-1981 
 
Swerdlow RH, Khan SM (2004) A "mitochondrial cascade hypothesis" for sporadic Alzheimer's 
disease. Med Hypotheses 63: 8-20 
 
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and 
adult fibroblast cultures by defined factors. Cell 126: 663-676 
 
Tan JM, Wong ES, Kirkpatrick DS, Pletnikova O, Ko HS, Tay SP, Ho MW, Troncoso J, Gygi SP, Lee MK, 
Dawson VL, Dawson TM, Lim KL (2008) Lysine 63-linked ubiquitination promotes the formation 
and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum 
Mol Genet 17: 431-439 
 
Tanaka A (2010) Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges 
damaged organelles from the vital mitochondrial network. FEBS Lett 584: 1386-1392 
 
Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W (1996) The gene defects 
responsible for familial Alzheimer's disease. Neurobiol Dis 3: 159-168 
 
Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol 
Chem 283: 29615-29619 
 
Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F (2009) The TBK1 adaptor and 
autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 10: 
1215-1221 
 
Thurston VC, Zinkowski RP, Binder LI (1996) Tau as a nucleolar protein in human nonneural cells 
in vitro and in vivo. Chromosoma 105: 20-30 
 
Trinczek B, Ebneth A, Mandelkow EM, Mandelkow E (1999) Tau regulates the 
attachment/detachment but not the speed of motors in microtubule-dependent transport of single 
vesicles and organelles. J Cell Sci 112 ( Pt 14): 2355-2367 
 
Turner PR, O'Connor K, Tate WP, Abraham WC (2003) Roles of amyloid precursor protein and its 
fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70: 1-32 
 
 
References 
 
136 
 
Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, 
Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS (2008) Fission and selective fusion 
govern mitochondrial segregation and elimination by autophagy. EMBO J 27: 433-446 
 
van der Bliek AM, Shen Q, Kawajiri S (2013) Mechanisms of mitochondrial fission and fusion. Cold 
Spring Harb Perspect Biol 5 
 
Van Humbeeck C, Cornelissen T, Hofkens H, Mandemakers W, Gevaert K, De Strooper B, 
Vandenberghe W (2011) Parkin interacts with Ambra1 to induce mitophagy. J Neurosci 31: 10249-
10261 
 
Vazin T, Ball KA, Lu H, Park H, Ataeijannati Y, Head-Gordon T, Poo MM, Schaffer DV (2014) Efficient 
derivation of cortical glutamatergic neurons from human pluripotent stem cells: a model system to 
study neurotoxicity in Alzheimer's disease. Neurobiol Dis 62: 62-72 
 
Verwer RW, Dubelaar EJ, Hermens WT, Swaab DF (2002) Tissue cultures from adult human 
postmortem subcortical brain areas. J Cell Mol Med 6: 429-432 
 
Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M (2010) Direct conversion of 
fibroblasts to functional neurons by defined factors. Nature 463: 1035-1041 
 
Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, Kim J, May J, Tocilescu MA, Liu W, Ko HS, 
Magrane J, Moore DJ, Dawson VL, Grailhe R, Dawson TM, Li C, Tieu K, Przedborski S (2010) PINK1-
dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107: 378-
383 
 
Wang D, Epstein D, Khalaf O, Srinivasan S, Williamson WR, Fayyazuddin A, Quiocho FA, Hiesinger 
PR (2014a) Ca2+-Calmodulin regulates SNARE assembly and spontaneous neurotransmitter 
release via v-ATPase subunit V0a1. J Cell Biol 205: 21-31 
 
Wang X, Perry G, Smith MA, Zhu X (2010) Amyloid-beta-derived diffusible ligands cause impaired 
axonal transport of mitochondria in neurons. Neurodegener Dis 7: 56-59 
 
Wang X, Su B, Fujioka H, Zhu X (2008a) Dynamin-like protein 1 reduction underlies mitochondrial 
morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease 
patients. Am J Pathol 173: 470-482 
 
Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial 
fission and fusion in Alzheimer's disease. J Neurosci 29: 9090-9103 
 
Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008b) Amyloid-beta 
overproduction causes abnormal mitochondrial dynamics via differential modulation of 
mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105: 19318-19323 
 
Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X (2014b) Oxidative stress and mitochondrial 
dysfunction in Alzheimer's disease. Biochim Biophys Acta 1842: 1240-1247 
 
Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, Rice S, Steen J, LaVoie MJ, Schwarz TL 
(2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial 
motility. Cell 147: 893-906 
 
Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC (2003) Alpha-Synuclein is degraded by 
both autophagy and the proteasome. J Biol Chem 278: 25009-25013 
 
Wild P, McEwan DG, Dikic I (2014) The LC3 interactome at a glance. J Cell Sci 127: 3-9 
 
Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W, Crowther RA (1988) Structural 
characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U 
S A 85: 4884-4888 
 
References 
 
137 
 
 
Witte ME, Bol JG, Gerritsen WH, van der Valk P, Drukarch B, van Horssen J, Wilhelmus MM (2009) 
Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis 
brain lesions. Neurobiol Dis 36: 445-452 
 
Wolf DS, Gearing M, Snowdon DA, Mori H, Markesbery WR, Mirra SS (1999) Progression of regional 
neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. Alzheimer 
Dis Assoc Disord 13: 226-231 
 
Wolozin BL, Pruchnicki A, Dickson DW, Davies P (1986) A neuronal antigen in the brains of 
Alzheimer patients. Science 232: 648-650 
 
Wong E, Cuervo AM (2010) Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13: 
805-811 
 
Wong YC, Holzbaur EL (2014) Optineurin is an autophagy receptor for damaged mitochondria in 
parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci U S A 
111: E4439-4448 
 
Wood JG, Mirra SS, Pollock NJ, Binder LI (1986) Neurofibrillary tangles of Alzheimer disease share 
antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci 
U S A 83: 4040-4043 
 
Woodruff G, Young JE, Martinez FJ, Buen F, Gore A, Kinaga J, Li Z, Yuan SH, Zhang K, Goldstein LS 
(2013) The presenilin-1 DeltaE9 mutation results in reduced gamma-secretase activity, but not 
total loss of PS1 function, in isogenic human stem cells. Cell Rep 5: 974-985 
 
Wutz A (2012) Epigenetic alterations in human pluripotent stem cells: a tale of two cultures. Cell 
Stem Cell 11: 9-15 
 
Xie Z, Nair U, Klionsky DJ (2008) Atg8 controls phagophore expansion during autophagosome 
formation. Mol Biol Cell 19: 3290-3298 
 
Xu RH, Sampsell-Barron TL, Gu F, Root S, Peck RM, Pan G, Yu J, Antosiewicz-Bourget J, Tian S, 
Stewart R, Thomson JA (2008) NANOG is a direct target of TGFbeta/activin-mediated SMAD 
signaling in human ESCs. Cell Stem Cell 3: 196-206 
 
Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H, Suzuki N (2011) 
Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet 20: 
4530-4539 
 
Yamano K, Matsuda N, Tanaka K (2016) The ubiquitin signal and autophagy: an orchestrated dance 
leading to mitochondrial degradation. EMBO Rep 17: 300-316 
 
Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson D, 
Bandyopadhyay U, Jiang Y, Pawlik M, Peterhoff CM, Yang AJ, Wilson DA, St George-Hyslop P, 
Westaway D, Mathews PM, Levy E, Cuervo AM, Nixon RA (2011) Reversal of autophagy dysfunction 
in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory 
deficits. Brain 134: 258-277 
 
Youle RJ, Narendra DP (2011) Mechanisms of mitophagy. Nat Rev Mol Cell Biol 12: 9-14 
Young JE, Boulanger-Weill J, Williams DA, Woodruff G, Buen F, Revilla AC, Herrera C, Israel MA, 
Yuan SH, Edland SD, Goldstein LS (2015) Elucidating molecular phenotypes caused by the SORL1 
Alzheimer's disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 
16: 373-385 
 
Yu WH, Kumar A, Peterhoff C, Shapiro Kulnane L, Uchiyama Y, Lamb BT, Cuervo AM, Nixon RA 
(2004) Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: 
 
References 
 
138 
 
implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int J 
Biochem Cell Biol 36: 2531-2540 
 
Yue Z (2007) Regulation of neuronal autophagy in axon: implication of autophagy in axonal 
function and dysfunction/degeneration. Autophagy 3: 139-141 
 
Zeng H, Guo M, Martins-Taylor K, Wang X, Zhang Z, Park JW, Zhan S, Kronenberg MS, Lichtler A, Liu 
HX, Chen FP, Yue L, Li XJ, Xu RH (2010) Specification of region-specific neurons including forebrain 
glutamatergic neurons from human induced pluripotent stem cells. PLoS One 5: e11853 
 
Zhang F, Wen Y, Guo X (2014) CRISPR/Cas9 for genome editing: progress, implications and 
challenges. Hum Mol Genet 23: R40-46 
 
Zhu JH, Horbinski C, Guo F, Watkins S, Uchiyama Y, Chu CT (2007) Regulation of autophagy by 
extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell 
death. Am J Pathol 170: 75-86 
 
Zhu X, Perry G, Smith MA, Wang X (2013) Abnormal mitochondrial dynamics in the pathogenesis of 
Alzheimer's disease. J Alzheimers Dis 33 Suppl 1: S253-262 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
 
